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The Effects of Temperate Phage on Streptococcus Pneumoniae During
Colonization
Abstract
The first step in the pathogenesis of bacterial pathogens is colonization of the host. During colonization,
bacteria encounter host defenses, other commensal flora and selective pressures from lytic and temperate
bacteriophage. Phages and bacteria have a long history of co-evolution, which has led to bacterial resistance
mechanisms and phage counter-resistance mechanisms. One mechanism that phage have adapted is to
provide a fitness advantage to the host during colonization and disease, thereby promoting survival of both
bacteria and phages. Herein I examine how temperate phages affect streptococcal fitness while colonizing the
host, specifically looking at the interactions between Streptococcus pneumoniae, phage element Spn1 and
colonization of a murine nasopharynx.
Temperate phages have been identified in the genomes of up to 70% of clinical isolates of Streptococcus
pneumoniae. How these phages affect the bacterial host during colonization has not been previously
demonstrated. To ask this question, we used a clinical isolate, which carries a novel prophage Spn1. Spn1 was
detected as integrated and episomal forms both in vitro and in vivo. Surprisingly, Spn1 also expresses both
lytic and lysogenic genes during normal growth conditions. Since Spn1 could not be spontaneously cured, a
clean deletion was made to create the Spn1- strain. We used a competitive colonization assay in a murine
model to test the fitness of the Spn1+ vs. the Spn1- strain. The Spn1- strain outcompeted the Spn1+ strain
seventy-fold after seven days of colonization. To determine if Spn1 is causing a fitness defect by a trans-acting
factor, we made an Spn1+ mutant that does not become an episome or express any phage genes. This mutant
competed equally with the Spn1- strain, indicating that the fitness defect required expression of phage genes.
Further experiments interrogating autolysis, chain length and resistance to lysis by penicillin indicated
differences in the cell wall physiology associated with the presence of Spn1. This change in cell wall physiology
may be responsible for the fitness defect of Spn1+ strain during colonization. This study provides new insight
into how bacteria and prophages can interact and how these interactions may impact the relationship between
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ABSTRACT	  	  	  THE	  EFFECTS	  OF	  TEMPERATE	  PHAGE	  ON	  STREPTOCOCCUS	  PNEUMONIAE	  DURING	  COLONIZATION	  	  Hilary	  K.	  DeBardeleben	  Jeffrey	  N.	  Weiser	  	  The	  first	  step	  in	  the	  pathogenesis	  of	  bacterial	  pathogens	  is	  colonization	  of	  the	  host.	  During	  colonization,	  bacteria	  encounter	  host	  defenses,	  other	  commensal	  flora	  and	  selective	  pressures	  from	  lytic	  and	  temperate	  bacteriophage.	  Phages	  and	  bacteria	  have	  a	  long	  history	  of	  co-­‐evolution,	  which	  has	  led	  to	  bacterial	  resistance	  mechanisms	  and	  phage	  counter-­‐resistance	  mechanisms.	  One	  mechanism	  that	  phage	  have	  adapted	  is	  to	  provide	  a	  fitness	  advantage	  to	  the	  host	  during	  colonization	  and	  disease,	  thereby	  promoting	  survival	  of	  both	  bacteria	  and	  phages.	  Herein	  I	  examine	  how	  temperate	  phages	  affect	  streptococcal	  fitness	  while	  colonizing	  the	  host,	  specifically	  looking	  at	  the	  interactions	  between	  Streptococcus	  pneumoniae,	  phage	  element	  Spn1	  and	  colonization	  of	  a	  murine	  nasopharynx.	  	  Temperate	  phages	  have	  been	  identified	  in	  the	  genomes	  of	  up	  to	  70%	  of	  clinical	  isolates	  of	  Streptococcus	  pneumoniae.	  How	  these	  phages	  affect	  the	  bacterial	  host	  during	  colonization	  has	  not	  been	  previously	  demonstrated.	  To	  ask	  this	  question,	  we	  used	  a	  clinical	  isolate,	  which	  carries	  a	  novel	  prophage	  Spn1.	  Spn1	  was	  detected	  as	  
	  
v	  
integrated	  and	  episomal	  forms	  both	  in	  vitro	  and	  in	  vivo.	  Surprisingly,	  Spn1	  also	  expresses	  both	  lytic	  and	  lysogenic	  genes	  during	  normal	  growth	  conditions.	  Since	  Spn1	  could	  not	  be	  spontaneously	  cured,	  a	  clean	  deletion	  was	  made	  to	  create	  the	  Spn1-­‐	  strain.	  We	  used	  a	  competitive	  colonization	  assay	  in	  a	  murine	  model	  to	  test	  the	  fitness	  of	  the	  Spn1+	  vs.	  the	  Spn1-­‐	  strain.	  The	  Spn1-­‐	  strain	  outcompeted	  the	  Spn1+	  strain	  seventy-­‐fold	  after	  seven	  days	  of	  colonization.	  To	  determine	  if	  Spn1	  is	  causing	  a	  fitness	  defect	  by	  a	  trans-­‐acting	  factor,	  we	  made	  an	  Spn1+	  mutant	  that	  does	  not	  become	  an	  episome	  or	  express	  any	  phage	  genes.	  This	  mutant	  competed	  equally	  with	  the	  Spn1-­‐	  strain,	  indicating	  that	  the	  fitness	  defect	  required	  expression	  of	  phage	  genes.	  Further	  experiments	  interrogating	  autolysis,	  chain	  length	  and	  resistance	  to	  lysis	  by	  penicillin	  indicated	  differences	  in	  the	  cell	  wall	  physiology	  associated	  with	  the	  presence	  of	  Spn1.	  This	  change	  in	  cell	  wall	  physiology	  may	  be	  responsible	  for	  the	  fitness	  defect	  of	  Spn1+	  strain	  during	  colonization.	  This	  study	  provides	  new	  insight	  into	  how	  bacteria	  and	  prophages	  can	  interact	  and	  how	  these	  interactions	  may	  impact	  the	  relationship	  between	  bacteria	  and	  the	  host.	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Streptococcus pneumoniae, the pneumococcus, is a gram-positive organism and member 
of the lactic acid bacteria. Its closest relatives are S. mitis and S. oralis, commensal 
organisms that occupy the same niche, the human nasopharynx (145). Further 
classification of the pneumococcus relies on the immunogenic properties of its capsule 
(15). The capsule is a thick polysaccharide layer, covalently linked to the cell wall. There 
are over ninety known serotypes, which have been given number/letter designations. 
Capsule type does not necessarily indicate genotype since pneumococci are known to 
switch capsular types through natural transformation. Therefore, there is also a separate 
classification system that relies on multi-locus sequence typing. However, the capsule 





The pneumococcus was first identified in 1880 by Sternberg who isolated it from septic 
rabbits that had been injected with his saliva and separately by Pasteur from the saliva of 
an infant. The connections between the pneumococcus and various disease states such as 
	  
3	  
pneumonia and otitis media were made within ten years of its discovery.  Initial 
observations also noted the presence of capsule, the pneumococcal virulence factor that 
would eventually be used to produce a vaccine. (6) 
 
Over the years the pneumococcus has served as a model bacterium for many important 
discoveries in cell and molecular biology. Following its discovery a scientist named Hans 
Christian Gram, working under Carl Friedlander to identify organisms responsible for 
causing pneumonia, developed a test to differentiate bacteria in histological samples. It 
was this test that first differentiated pneumonia caused by the pneumococcus vs. 
Klebsiella pneumoniae and ultimately was used to categorize almost all bacterial species 
into two groups, Gram-positive and Gram-negative. The Gram stain is a method so 
simple and effective that it is still used extensively today. (6) 
 
The pneumococcal capsule and its role in virulence also led to the discovery of 
transformation and the biological properties of DNA.  Bacteriologist Fred Griffith first 
noted the smooth vs. rough colony morphology indicative of the presence of a capsule 
and further determined that lack of a capsule meant a significant decrease in virulence of 
the pneumococcus.  He infected mice with the avirulent rough colonies mixed with heat 
killed smooth colonies and recovered smooth colonies from the mice who succumbed to 
infection.  He called this process transformation since the living bacteria were 
transformed from rough to smooth colony morphology (61). Oswald Avery expanded on 
this study and showed only DNA from the smooth colonies was required for 
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transformation (8).  This established DNA as the biological molecule responsible for 
heredity and created the field of modern molecular biology. 
 
Research on the pneumococcus has also led to historic findings in the field of 
immunology. Early on in pneumococcal research, it was established that capsule was 
immunogenic. Neufeld based his quellung reaction on this property of the capsule and 
began the identification of serotypes (112). At the time it was thought that only proteins 
could be immunogenic and that the capsule must be similar to a protein or associated 
with a protein. This notion was finally overturned when biochemical studies on the 
capsule conclusively showed the pneumococcal capsule is a polysaccharide (7). 
Furthermore, the protective effects of passive immunization with anti-sera, which we 
now know are largely due to antibodies to the capsule, were first demonstrated in a 




Treatment of the pneumococcus is largely dependent on beta-lactam antibiotics.  After 
the discovery of penicillin, the potential for the pneumococcus to develop resistance to 
antibiotics was very quickly appreciated (53). However, the appearance of clinical 
isolates resistant to penicillin did not occur until 1965 and resistance to beta-lactams rose 
in prevalence throughout the 1970s (5). By the late 90’s antibiotic resistance was rampant 
amongst pneumococci with many strains resistant to multiple drugs. Introduction of the 
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conjugate vaccine reduced beta-lactam resistance among invasive isolates by 57% due to 
the fact that the serotypes included in the vaccine were also the most likely to be 
penicillin resistant. However, this study also observed an increase in non-susceptible 
isolates amongst non-vaccine strains, particularly 19A (84). 
 
The rise in antibiotic resistance amongst pneumococci has led to an interest in developing 
phage lysins as antimicrobial agents. Phage lysins are proteins produced by phage in 
order to lyse the cell at the end of the phage life cycle. Pneumoccocal phage lysin Cp1-l 
has been shown to reduce the incidence of disease progression from colonization to otitis 
media when applied intranasally in a mouse model (102). Most phage lysins are specific 
to the host bacterium from which the phage was isolated. The strength and limitation of 
phage lysins as antimicrobial agents lie somewhat paradoxically in their specificity. 
While ideally an antimicrobial would be specific enough to eliminate only the pathogen 
responsible for disease, the lack of rapid and sensitive diagnostic tools to identify disease-




Pneumococcal capsule is the major antigen and antibodies against the capsule are 
protective against pneumococcal colonization and disease. Several vaccines based on the 
capsule are in use today. The 23-valent polysaccharide vaccine is recommended for use 
in the elderly and others at risk for pneumococcal disease. More recently the 7-valent 
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conjugated vaccine, PCV7, was introduced into the vaccine program for children. This 
vaccine has been successful at eliminating pneumococcal colonization and disease not 
only in the children vaccinated but also in the elderly population, which indicates that the 
vaccine also provides herd immunity (66, 164). Each of these vaccines is only effective 
against the capsule types that they target. Other capsule types are increasing in prevalence 
after the introduction of the conjugate vaccine, a phenomenon referred to as “serotype 
replacement” (110). With over 90 known capsule types of S. pneumoniae, and the high 





Colonization is a precursor to disease 
 
The pneumococcus is responsible for roughly one million deaths worldwide annually. 
Disease outcomes resulting from pneumococcal infection include pneumonia, otitis 
media, septicemia and meningitis. Disease largely affects young children and the elderly. 
The first step in the pathogenesis of all pneumococcal disease is colonization of the 
human nasophayrnx. Colonization is asymptomatic. When the pneumococcus leaves this 
niche and enters normally sterile body sites such as the lung, middle ear or bloodstream, 
pneumococcal disease occurs. However, disease is thought to be an evolutionary dead 




Progression to disease is more likely in the context of co-infection or immune 
suppression. The most common co-infection leading to pneumococcal pneumonia is with 
the influenza virus. In a chinchilla model of otitis media, co-infection with S. pneumoniae 
and influenza A virus significantly increased likelihood of disease compared to S. 
pneumoniae or influenza A virus alone (58).  Experimental infection of adult volunteers 
with influenza A virus also showed an increased likelihood of acquiring nasopharyngeal 
carriage of S. pneumoniae (154). The mechanism by which the influenza virus increases 




Pneumococcal colonization is most prevalent in children. By the age of one year, nearly 
100% of children have tested positive for pneumococcal carriage (4). There is a drop off 
in carriage rates after four years of age and further decreases during adulthood (147). 
Though colonization is cleared within a few months, children are often serially colonized 
by different serotypes. Repeated colonization may lead to a build-up of immunity to non-
capsule antigens, which leads to the decrease in susceptibility during adulthood. 
However, adults older than sixty-five have a resurgence in susceptibility to pneumococcal 
disease, possibly due to declining immune function (147). Colonization in children is the 
main reservoir for disease and transmission (162). Reduction in rates of colonization 
amongst children has led to a reduction in pneumococcal disease in the entire population, 
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especially the elderly (66). 
 
Animal models of colonization 
 
Several animal models are actively used to study different bacterial and host factors 
involved in pneumococcal colonization. The most common model animal used is mice. In 
this model, bacteria are inoculated into unanaesthetized adult mice. Colonization persists 
for approximately twenty days depending on the strain of pneumococcus used. Mice are 
particularly easy to work with and a common model for all biomedical research. 
Therefore, investigation of host factors using genetic approaches is much easier in a 
mouse model than perhaps any other mammalian model system. However, not all strains 
of pneumococci can colonize mice. Also adult mice do not transmit the bacteria even 
when co-housed making studies on transmission limited. Other models are not as 
tractable as mice but have other benefits. Chinchilla models are used to study progression 
from colonization to otitis media due to the anatomy of their ears (58). Initial 
colonization studies were done in infant rats which can be colonized by a greater variety 
of pneumococcal strains (161). A ferret model was developed to study transmission (103) 
but was quickly replaced by an infant mouse model (49). Lastly, human carriage models 
are being developed to study colonization since carriage is a relatively safe, 





Dynamics of pneumococcal colonization 
 
Though the carriage state is largely considered to be asymptomatic, in both human and 
mouse models of colonization pneumococcal carriage is protective against secondary 
infection (20). This indicates an active host response to the pneumococcus during 
colonization which must be countered in order for the pneumococcus to persist. 
 
The first obstacle encountered by the pneumococcus upon inoculation into a host is 
mucocilliary-mediated clearance.  The pneumococcus overcomes this host defense by 
expressing a negatively charged capsule, which repels the negatively charged sialic acid 
residues on mucus. The capsule allows the pneumococcus to avoid agglutination in the 
mucus layer and move to the epithelial surface (111).  Upon reaching the epithelial 
surface the pneumococcus must adhere to cells in order to persist. Adherence factors 
CbpA and PsaA are both involved in adherence to epithelial cells binding to human 
immunoglobulin receptor PlgL and E-cadherins respectively (65). The glycosidases 
NanA, BgaC and SpuA have also been shown to improve adherence likely by removing 
sugars that otherwise mask receptors on the epithelial cell surface (83). 
 
Within 1-3 days of colonization there is an influx of neutrophils into the nasopharynx, 
however this influx is not sufficient to clear the pneumococcus.  Instead pneumococcal 
density declines only after macrophages are recruited to the site of colonization at 7-10 
days post inoculation (42). Pneumococci employ several factors to avoid 
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opsonphagocytosis by neutrophils. The main component in avoiding complement 
deposition is capsule. However, exoglycosidases NanA, StrH and BgdA have also been 
shown to inhibit complement deposition (37). Mice lacking T-Cells and B-Cells (SCID 
mice) and mice lacking MHCII complex, which have significantly reduced numbers of 
CD4 T-Cells, are impaired in clearance of pneumococcal colonization indicating that 
clearance is also dependent on CD4 T-cells (150). 
 
The development of antibody during primary colonization is not important for bacterial 
clearance (100). However, antibody is important for blocking secondary infection. In a 
human challenge study protection from colonization correlated with serum antibody to 
the protein PspA, however this protein is antigenically variable (101). Additionally, 
antibody generated against an unencapsulated strain was able to protect against all 
serotypes of the pneumococcus in a mouse model of colonization, though the combiation 




Several epidemiological studies have shown simultaneous colonization by multiple 
serotypes of S. pneumoniae. The likelihood of this happening is increased in young 
children and in areas endemic for pneumococcal disease (25). Furthermore, the 
emergence of serotype replacement strains is indicative of the possibility that vaccine 
strains had previously been able to outcompete the non-vaccine strains.  Therefore, by 
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eliminating the vaccine strains the vaccine has expanded the niche for non-vaccine 
strains. This hypothesis has led to inquiries about intra-species competition among 
pneumococci. Initial studies show that colonization by one pneumococcal strain can 
inhibit another isogenic strain from establishing colonization (91). Further studies into the 
mechanism of competition amongst pneumococci led to the discovery of bacteriocins. 
 
Bacteriocins are small proteins, similar to anti-microbial peptides found in eukaryotes, 
that are used to compete with similar bacterial species. The Blp locus of Streptococcus 
pneumoniae encodes a regulatory region, a bacteriocin and an immunity locus (44). Two 
strains of capsule types 6A and 19A were able to inhibit growth of their isogenic Blp 
locus mutants and the growth of a separate strain, Tigr4, in vitro.  The 19A strain was 
also able to inhibit colonization of its isogenic Blp mutant and Tigr4 in a mouse model. 
Bacteriocin loci of four other strains were tested and found to have activity against not 
only S. pneumoniae but also against other members of the genus Streptococcus and two 
non-streptococcal species, Micrococcus luteus and Lactococcus lactis (93). The 
importance of co-colonization and competition amongst pneumococci and with other 
colonizing bacteria is highlighted by the conservation of bacteriocins across many 




The human nasopharynx is colonized by many species of bacteria and constitutes a 
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complex ecology (89). Many pathogens of note, such as Staphylococcus aureus, 
Haemophilus influenza and Neisseria meningitidis, directly compete with the 
pneumococcus for space and resources within this niche. The production of hydrogen 
peroxide by S. pneumoniae inhibits growth of many co-colonizing species (119). 
However for some species it has been shown that a much more complex interaction is 
occurring. 
 
In large scale epidemiological studies, it has been noted that colonization by S. 
pneumoniae is protective against colonization by S. aureus While S. aureus is affected by 
hydrogen peroxide produced by S. pneumoniae in vitro, direct competition via this 
mechanism has not been shown in vivo. Furthermore, in hosts where the immune system 
is compromised, no inverse correlation is seen between these two species. Cross-reactive 
antibodies generated against S. pneumoniae are protective against colonization by S. 
aureus in a mouse model. This may indicate that competition between the pneumococcus 
and S. aureus is immune mediated (90). 
 
Another common pathogen, Haemophilus influenzae competes with the pneumococcus 
for space and resources within the human nasopharynx. Co-colonization with the 
pneumococcus and H. influenzae leads to rapid clearance of the pneumococcal strain that 
is dependent on opsonophagocytic killing (95). Co-colonization of either airway 
epithelial cells or a mouse model of colonization leads to synergistic increase in the 
production of cytokines and influx of neutrophils (123). This host influx is not sufficient 
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to clear H. influenzae but rather eliminates competing flora, such as the pneumococcus. 
Pneumococci with capsule types that increase resistance to opsonophagocytosis, and 
therefore more virulent strains of pneumococci, are more likely to survive this increased 
host influx (94). Thus it is likely that competition with H. influenzae has driven the 






Streptococcus pneumoniae naturally produces a large amount of hydrogen peroxide, 
which can be lethal to the bacterium. Therefore it is traditionally grown on agar 
containing sheep’s blood as a source of catalase, which catalyzes the reaction converting 
hydrogen peroxide to water and oxygen. Sheep’s blood agar is opaque, making 
observations on colony morphology difficult. However, addition of purified catalase to 
tryptic soy agar (TSA) allowed the bacteria to be grown on a clear medium. This enabled 
researchers to make observations on the variations in colony morphology of the 
pneumococcus. (161) 
  
When grown on TSA, Streptococcus pneumoniae exhibits two distinct colony 
morphologies noted as transparent or opaque (Figure 2A). This phenotype is phase 
variable meaning there is likely random switching between the two morphologies. 
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However, the genetic basis for the phase variability, which resembles a bistable switch, is 
unknown. Biochemical analysis of opaque vs. transparent strains indicated differences in 
amount of capsule and teichoic acids which may contribute to the visible phenotype (82). 
However, it should be noted that when capsule is genetically removed, variations in 
colony morphology are still visible meaning the basis for opacity includes other factors 
and may be multi-factorial. 
 
Colony morphology also plays a role in pneumococcal colonization and invasive disease. 
Transparent variants colonize the nasopharynx of infant rats at higher densities than the 
opaque variants. Furthermore, in one strain in this study, phase-switching was observed. 
In this strain an opaque variant was inoculated but a transparent variant was recovered 
indicating that the transparent morphology was selected for during colonization (161). In 
contrast, opaque variants are more virulent during invasive disease than transparent 
variants (82). This was determined using an intraperitoneal infection model in adult mice 
where injection with opaque strains resulted in 100% mortality and injection with 
transparent strains resulted in near 100% survival out to twenty days. In the few mice that 
did succumb to infection after injection with the transparent strain, it was noted that the 
bacteria recovered from the spleen had also phase-switched and became opaque variants. 






The pneumococcus was initially described as a diplococcus due to its cell morphology. 
Later the organism was reassigned to the genus Streptococcus after scientists determined 
that there is variation in chain length and because of additional phenotypic data. The 
mismatched timing of cell division and cell separation results in chain formation. Two 
proteins LytA and LytB are known to be involved in cell separation and division. LytA is 
a cell wall amidase and mutations in lytA have multiple phenotypic effects including the 
formation of long chains (Figure 2B) (130). LytB is responsible for separation following 
cell divison and mutants in lytB form very long chains with a characteristic tethering 
visible between cells (Figure 2C) (45). Chain length has been found to be important 
during colonization due to increased adherence to the epithelium by longer chained 
pneumococci (126). Conversely, short chained pneumococci are better adapted for 
invasive disease because their lower surface area per particle allows them to better evade 
complement deposition on the bacterial surface (38). 
 
Cell wall structure and synthesis 
 
The pneumococcal cell wall is synthesized at two points along the bacterial surface for 
elongation and division. These two steps are inversely regulated to maintain the ovoid 
shape of the cell. The two groups of genes responsible for cell wall synthesis, one for 
division and one for elongation, are homologous to those found in rod-shaped bacteria. 
The three major components of the cell wall peptidoglycan, wall teichoic acid and 
capsule are all synthesized at the mid-point in the cell. Peptidoglycan precursors are 
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synthesized in the cytosol and linked via a phosphate bond to the cell membrane. Each 
precursor is theoretically flipped to the cell surface where it is added to the already 
synthesized peptidoglycan. Also at this point, penicillin-binding proteins begin cross-
linking the peptide bridges forming the lattice structure of peptidoglycan. Teichoic acids 
and capsule are synthesized in the cytosol and exported by separate machinery from the 
peptidoglycan. At the same zone of new growth they are inserted and covalently linked to 
the peptidoglycan. A complex network of signaling pathways tightly regulates synthesis 
of these three components. (98)  
 
Autolytic growth and LytA 
 
The pneumococcus is naturally autolytic, meaning in stationary phase the bacteria release 
a lytic amidase resulting in lysis of the entire bacterial culture. The amidase responsible 
for this action is LytA (130). LytA is a choline binding protein, which is associated with 
the cell wall due to choline containing teichoic acids (81). LytA has no known secretion 
signal. It was proposed that LytA is transported to the cell wall by binding teichoic acids 
while they are inside the cell during cell wall synthesis (56). LytA is specifically 
associated with the nascent peptidoglycan likely because of its role in cell division and 
separation (104). Crystal structures of LytA revealed a rigid choline binding domain and 
a more flexible amidase domain, which has specific substrate requirements indicating that 
regulation of LytA may be at the substrate level (105). LytA is activated and will lyse the 
bacterial cell when membrane integrity is lost causing a change in the proton gradient 
	  
17	  
(56). LytA has been found to be important in pneumococcal virulence. After intranasal 
inoculation, mutants in lytA had lower bacterial titers than the wild type in the 
nasopharynx at 24 hours, in the lungs and blood at 48 hours and were unable to reach the 
CSF after 96 hours. This study also found defects in the virulence of lytA mutants when 
inoculated directly into the lungs, intraperitoneally or intravenously (116). The 
mechanism for LytA’s role during pneumococcal pathogenesis is unclear. 
 
The importance of the cell wall in vivo 
 
As a Gram positive pathogen the pneumococcal cell wall is surface exposed and therefore 
able to directly interact with the mammalian host. Many important virulence factors are 
choline binding proteins. These proteins bind to the choline found on cell wall teichoic 
(also known as the c-polysaccharide) and lipoteichoic acids. Some examples include 
LytA, CbpA, which is known to improve bacterial adherence to the epethelium and bind 
IgG receptors, and PspA which can prevent complement deposition on the bacterial 
surface (81). Phosphorylcholine in the cell wall can directly interfere with host responses 
by binding rPAF (the receptor for Platelet Activating Factor) and activating host 
signaling which can lead to downstream effects on the immune response (35). Another 
important virulence factor, capsule, is covalently linked to peptidoglycan, the main 
component of the cell wall. 
 
The cell wall is directly exposed to host defenses, which include enzymes that can break 
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down peptidoglycan. The most prevalent peptidoglycan-degrading enzyme on the 
mucosal surface is lysozyme. Many successful pathogens, including Streptococcus 
pneumoniae, alter their cell wall in order to resist lysozyme (43). Furthermore, after they 
have been broken down by lysozyme, the host can detect components of the bacterial cell 
wall through pattern recognition receptors such as Nod2 and TLR2 (120, 142). This 






There are two types of phages, temperate and virulent. Both types will adsorb to the 
bacterial surface and inject phage DNA into the bacterial cell. A temperate phage, 
depending on the conditions within the cell, will enter either a lytic or lysogenic pathway.  
A virulent phage can only enter the lytic pathway. Phages that follow the lytic pathway 
usually hijack the bacterial machinery to transcribe and translate genes for DNA 
replication, capsids, tail and lysis of the bacterial cell.  New phages are assembled and 
escape the bacterial cell after lysis has occurred. A temperate phage that follows the 
lysogenic pathway will not replicate but integrate into the bacterial genome at a specific 
site where it is called a prophage. It remains in this state as the bacteria grow and divide 
and under certain conditions in the cell, usually in times of bacterial stress, the prophage 




The regulation of temperate phages has been most thoroughly studied in lambda phages, 
which infect the species E. coli.  Lambda phage genomes are organized by function with 
the lysogeny genes all encoded in the same direction on one end and the genes for the 
lytic pathway encoded in the other direction away from the lysogeny cluster.  A 
regulatory region between these two clusters contains three operator sites called OR1, 
OR2 and OR3. The lysogeny cluster encodes a C1repressor, which maintains the 
integrated state of the prophage.  It binds to the first operator site to repress the lytic 
genes.  Binding to the second site promotes transcription of itself.  Binding to the third 
site represses its own transcription.  When the bacterial cell experiences stress it 
upregulates proteases. These proteases cleave the C1repressor.  Once enough of the 
repressor has been cleaved to prevent binding to the OR1 site the expression of lytic genes 
is no longer repressed.  The first lytic gene is cro, another regulatory protein.  Cro further 
promotes expression of the lytic genes by binding the second operator site.  This system 




In an effort to resist predation by phage, bacteria have evolved numerous mechanisms 
that target phage at all points the phage cycle. For example bacteria have evolved 
restriction modification (RM) systems to distinguish self DNA from non-self DNA. An 
RM system involves a DNA methylase and a restriction enzyme that is inhibited by 
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methylation. This allows unmethylated DNA, such as an invading phage genome, to be 
cut by the restriction enzyme while methylated bacterial DNA is unaffected. Bacteria 
have also evolved a CRISPR-Cas system to achieve a similar end, the digestion of 
invading phage DNA. CRISPRs encode short sequences of previously encountered 
foreign DNA called a spacer. When the same DNA sequence is encountered the spacer 
binds to the foreign DNA and the Cas family of proteins recognizes this interaction and 
cuts up the invading DNA. Bacteria will also alter or cover outer surface proteins with 
other proteins or sugars, which are used by phages as receptors for adsorption. Phages 
have co-evolved to counteract all of these mechanisms. Phages have been shown to 
encode their own methylases to counteract restriction enzymes. Point mutations in DNA 
sequences targeted by CRISPRs are enough to evade Cas systems. Lastly, phages evolve 
to bind to new receptors and digest sugars to reach receptors on the bacterial surface for 
adsorption. This evolutionary arms race is a classic example of predator prey relationship 
and is indicative of the enormous selective pressure applied by phages on bacteria in the 
environment. (85)  
 
The pneumococcus has two restriction modification systems, DpnI and DpnII. These 
systems are mutually exclusive because DpnI restricts only methylated DNA while DpnII 
restricts unmethylated DNA. This allows survival of phage attack in a mixed population. 
Phages produced in a DpnII containing bacterium will be restricted when infecting a 
DpnI containing bacterium and vice versa. However, restriction of foreign DNA presents 
a problem for the pneumococcus during natural transformation, a process that improves 
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survival of the population by creating diversity (137). The pneumococcus overcomes this 
by have enzymes specific to cleaving double stranded DNA, which is how phage DNA is 
injected into a cell. Also when competence is induced, the DpnII system upregulates a 
methylase that will methylate single stranded DNA as it enters the cell, thus protecting 
foreign DNA taking up during transformation. (80) 
 
The pneumococcal capsule may be another phage resistance mechanism since capsule 
prevents phage infection in a laboratory setting (17). There is very little known about the 
specific receptors phage use to adsorb to the pneumococcus, however, any receptor 
would likely be covered by the capsule. In natural settings phages may be able to 
overcome the presence of the capsule or there may be a population of unencapsulated 
pneumococci that serve as a reservoir for phage. 
 
Lastly, CRISPR-Cas systems have not been identified in any sequenced pneumococcal 
strains. CRISPR-Cas systems have been artificially introduced to pneumococci and can 
inhibit uptake of foreign DNA including natural transformation (19). It is likely that 
because of the inhibition of natural transformation, which is advantageous to the bacterial 




Prophages have been identified in up to 70% of clinical isolates of Streptococcus 
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pneumoniae. Initial studies identified the phage lysin by homology to the bacterial gene 
lytA (122). In this study southern blots with probes for lytA resulted in multiple bands 
indicating multiple copies of lytA. It was further determined that isolates containing 
multiple bands were reactive to chemical induction of prophages by mitomycin C and 
supernatants of these isolates contained phage particles detected in electron micrographs. 
Later studies were more specific in the identification of prophages by using a PCR based 
system that detected multiple phage genes (128). This system was less likely to find 
phage remnants and they found that about 50% of the clinical isolates they tested 
harbored phages. The prophages were clustered based on sequence similarity into three 
distinct groups simply numbered 1, 2 and 3. Group 1 was the most common type of 
prophage found followed by group 2 and then 3. There were no significant correlations 
between the phage groups and origin or serotype of the bacterial isolates. Each of these 
studies only identified phages with known, albeit common, phage genes.  Later studies 
were less biased by using whole genome sequencing. One study in particular focused on 
a single clone of S. pneumoniae, PMEN-1 (33). Though they were not specifically 
looking for phage, they found prophages from all three previously identified groups in up 
to 30% of the isolates sequenced. They also identified a new group of phages (Group 2b) 
that integrate into the ComE locus and inhibit competence in S. pneumoniae. This 
inhibition of competence led to a halt in the evolution of the organism not seen in strains 
that did not harbor group 2b prophages. This is an example of how phage might 




The PMEN-1 study determined that the accessory genome, genes that are most variable 
between isolates, largely consisted of prophages indicating phages are a source of 
diversity for the pneumococcus (33). In other streptococci, such as S. pyogenes, phage are 
the main source of diversity and carry many virulence factors and toxins. Therefore, the 
phage profile often determines the virulence of the organism (106). This does not hold 
with S. pneumoniae. No known virulent toxins are encoded on pneumococcal phages 
(127). Also the phages of S. pyogenes have been shown to lysogenize other streptococcal 
species such as S. suis and S. equi thus bringing new virulence factors to emerging 
pathogens (73, 144). However, no pneumococcal phages are thought to have originated in 
any other species. 
 
Phenotypic effects of pneumococcal phages 
 
Pneumococcal phages can affect biofilm formation, colony morphology and adherence. 
Extracellular DNA is an important part of the extracellular matrix in pneumococcal 
biofilms (63). By lysing a sub-population of bacteria, prophages contribute to the 
presence of extracellular DNA (30). Consequently, pneumococcal lysogens form thicker 
biofilms. The presence of pneumococcal phage MM1 caused a transparent colony 
morphology, which has preciously been associated with improved fitness during 
colonization (92). Furthermore, MM1 lysogens had improved adherence to A549 cells in 
the Tigr4 background independent of colony morphology. The mechanism for this 
increased adherence is unknown but this study did not address the possibility of increased 
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biofilm formation affecting adherence. Both of these phenotypic effects could improve 
bacterial fitness during colonization. 
 
Regulation of integration and excision 
 
The attachment site and integration of pneumococcal phages has only been studied in one 
phage, MM1. MM1 has a 15bp attachment site located, when the phage is in a circular 
form, between the lysin and the integrase in a non-coding region. The phage attachment 
site is an exact match to the bacterial attachment site located within the coding region in 
the 3’ end of the coding region of a conserved hypothetical protein (60). A non-
replicating plasmid encoding just the phage integrase (and no other phage genes) can 
integrate into the bacterial genome using this attachment site. Regulation of the integrase 
and other lysogeny genes likely depends on two promoter regions located between the 
lytic and lysogeny clusters. C1Repressor can bind to and repress gene expression at both 
of these promoters, which indicates a “genetic switch” similar to what is seen in 
lambdoid phages (115).  
 
Pneumococcal phage genomes 
 
There are several studies comparing temperate phages within streptococcal species 
including S. suis, S. thermophilus and S. pneumoniae.  Temperate phage genomes from 
all three species were organized into functional clusters (lysogeny, replication, 
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packaging, morphology and lysis). These findings support the modular evolution theory, 
that phages have gene modules that recombine to create new phages.  However, in the 
phages of S. pneumoniae recombination was also seen at the single gene level. All 
temperate phages of the pneumococcus in this study carried a LytA homologue in the 
lysis cluster, however virulent phages have a different lysin. There was a high level of 
conservation amongst these phages in the integrase gene as well.  Within the other 
functional clusters there is more diversity particularly within the morphology cluster. 
Based on the nucleotide similarity, the ten phages were grouped into three families. (127) 
 
Putative virulence factors were only seen in two of the ten phages. Phage ϕSpn_6 
encoded a putative toxin/antitoxin system homologous to the MazEF system in E. coli. 
This system promotes maintenance of the phage by producing a stable toxin and an 
unstable antitoxin. When the phage is lost the unstable antitoxin is degraded and the 
stable toxin remains killing the bacteria (68). In E. coli the MazEF system is also 
important for bacterial stress responses. PblA and PblB found in S. mitis phage SM1 have 
been shown to bind to the surface of the bacterium and improve bacterial adherence to 
platelets (14). Phage ϕSpn_11 encoded a tail and tape measure protein similar to PblA 
and PblB.  The rest of the phages in this study, with the exception of the MM1 family, 
also encoded a protein similar to PblB. The role of the toxin system or PblA/B in vivo has 





Pneumococcal phage lysins 
 
Almost all known temperate phages of the pneumococcus contain similar phage lysins. 
These phage lysins are homologous to and functionally redundant with the bacterial 
protein LytA. Sequence homology of LytA and phage lysins was first noted in a study 
looking at the presence of LytA in clinical isolates. In this study, Southern blots to detect 
lytA showed two bands indicating two lytA genes. Further work determined that this 
second band indicated the presence of a homologous phage lysin (122). Recombination 
occurs frequently between phage lysins and LytA contributing to the diversity and 
evolution of these genes (109, 163). Chimeric enzymes mixing the choline binding and 
amidase domains of these two proteins are functional even when lacking a high degree of 
sequence similarity (50). Phage lysin Svl and LytA are functionally redundant during the 
last part of the phage cycle, phage progeny release (57). Phage lysins are usually secreted 
through holins, small proteins that aggregate to form pores in the membranes of cells. 
Pneumococcal phages encode 1-3 holins upstream of the lysin (127). However, 
pneumococcal phage lysins and LytA are likely secreted by a different mechanism, by 
binding choline-containing teichoic acids as the cell wall is synthesized (56). Both 





Figure 1. Tissue sections of pneumococcal colonization from 30m to 14 days (a-b). 
Pneumococci are stained in red using anti-capsular immunoflouresence. Epithelial cells 
are stained in blue using DAPI. Neutrophils are stained in green using anti-Ly6-G 






Figure	  2.	  Colony	  and	  cell	  morphology	  of	  Streptococcus	  pneumoniae	  A.	  Opaque	  and	  transparent	  colonies	  adapted	  from	  Weiser	  et	  al.	  1994	  B.	  Brightfield	  microscopy	  of	  pneumococcal	  strain	  Tigr4,	  wild	  type	  and	  ΔlytA	  mutant	  adapted	  from	  Dalia	  et	  al.	  2010.	  C.	  Cell	  morphology	  of	  the	  ΔlytB	  mutant	  adapted	  from	  De	  Las	  Rivas	  et	  al.	  2002
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Dissertation	  Goals	  	  	  The	  pneumococcus	  is	  a	  leading	  cause	  of	  bacterial	  pneumonia	  resulting	  in	  roughly	  one	  million	  deaths	  worldwide	  each	  year.	  The	  first	  step	  in	  the	  pathogenesis	  of	  pneumococcal	  disease	  is	  colonization.	  Blocking	  colonization	  prevents	  pneumococcal	  disease,	  therefore	  it	  is	  important	  to	  understand	  the	  bacterial	  and	  host	  factors	  involved	  in	  this	  step	  of	  pathogenesis.	  One	  ecological	  pressure	  important	  for	  all	  bacteria	  is	  that	  of	  bacteriophage.	  A	  high	  percentage	  of	  clinical	  isolates	  of	  pneumococci	  carry	  prophages.	  How	  these	  phages	  affect	  the	  pneumococcus	  during	  colonization	  is	  unclear.	  It	  is	  the	  goal	  of	  this	  dissertation	  to	  determine	  how	  phages	  might	  affect	  the	  pneumococcus	  during	  colonization.	  	  The	  first	  aim	  of	  this	  dissertation	  is	  to	  examine	  the	  effects	  of	  phage	  on	  related	  streptococcal	  species.	  In	  Chapter	  two	  I	  will	  discuss	  the	  diverse	  mechanisms	  by	  which	  phage	  can	  affect	  streptococci	  while	  colonizing	  or	  infecting	  a	  mammalian	  host.	  Though	  there	  are	  many	  known	  phage	  encoded	  toxins	  within	  streptococcal	  species,	  particularly	  for	  S.	  pyogenes,	  we	  will	  also	  discuss	  the	  full	  range	  of	  phage	  associated	  fitness	  advantages.	  These	  include	  phage	  promotion	  of	  diversity,	  phage	  mediated	  competition	  amongst	  different	  species	  or	  strains	  of	  streptococci	  and	  phage	  associated	  adherence	  factors	  such	  as	  directly	  encoded	  adhesins	  or	  assistance	  in	  biofilm	  formation.	  This	  variety	  of	  mechanisms	  sheds	  light	  on	  how	  phage	  can	  affect	  all	  pathogens	  including	  S.	  pneumoniae,	  the	  focus	  of	  this	  dissertaion.	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Effects	  of	  bacteriophage	  on	  interactions	  between	  bacteria	  and	  their	  
mammalian	  hosts:	  Lessons	  from	  streptococci	  	  Hilary	  DeBardeleben1	  and	  Jeffrey	  N.	  Weiser1,2	  	  	  Departments	  of	  Microbiology1	  and	  Pediatrics2,	  University	  of	  Pennsylvania	  School	  of	  Medicine,	  Philadelphia,	  Pennsylvania	  19104	  	  	  This	  review	  is	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  Infection	  and	  Immunity	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Abstract	  Bacteria	  and	  phage	  have	  a	  long	  history	  of	  co-­‐evolution	  involving	  resistance	  and	  counter-­‐resistance	  mechanisms.	  	  One	  strategy	  that	  phage	  have	  adopted	  is	  to	  improve	  bacterial	  fitness	  thereby	  rendering	  themselves	  advantageous	  to	  the	  survival	  of	  their	  bacterial	  host.	  Phages	  that	  have	  adopted	  this	  strategy	  are	  abundant	  in	  many	  clinically	  and	  agriculturally	  important	  species	  that	  reside	  primarily	  within	  a	  mammalian	  host.	  We	  have	  chosen	  to	  take	  an	  in	  depth	  look	  at	  the	  genus	  
Streptococcus,	  for	  which	  the	  effect	  of	  phage	  has	  been	  intensely	  studied,	  to	  explore	  the	  multiple	  ways	  that	  phage	  can	  affect	  their	  bacterial	  hosts	  during	  colonization	  and	  disease.	  	  Streptococcal	  phages	  have	  been	  shown,	  for	  example,	  to	  impact	  diversity	  and	  adaptation,	  antibiotic	  resistance,	  adherence,	  and	  virulence	  of	  their	  bacterial	  host.	  	  	  Streptococcal	  phages	  also	  affect	  their	  bacterial	  hosts’	  ability	  to	  compete	  in	  
vivo	  with	  other	  members	  of	  the	  same	  species	  or	  same	  genus.	  These	  mechanisms	  provide	  insight	  into	  the	  role	  of	  bacteriophage	  in	  the	  microbial	  ecology	  of	  bacterial	  pathogens	  and	  should	  be	  relevant	  to	  other	  bacterial	  species.	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Introduction	  An	  important	  and	  often	  overlooked	  factor	  in	  bacterial	  fitness	  and	  adaptation	  is	  the	  role	  of	  bacteriophage.	  Bacteria	  and	  phages	  have	  co-­‐evolved	  in	  a	  never-­‐ending	  arms	  race	  of	  resistance	  and	  counter-­‐resistance	  mechanisms.	  In	  many	  instances,	  phages	  have	  evolved	  to	  be	  useful	  to	  the	  bacterial	  host.	  	  In	  this	  way,	  a	  bacterial	  host	  that	  carries	  a	  prophage	  is	  more	  fit	  and,	  therefore,	  both	  the	  phage	  the	  bacteria	  carrying	  it	  are	  more	  likely	  to	  survive.	  Bacteria	  that	  colonize	  and	  infect	  mammalian	  hosts	  are	  no	  exception.	  	  A	  well	  known	  example	  of	  phage	  contributing	  to	  microbial	  pathogenesis	  is	  the	  phage-­‐encoded	  cholera	  toxin	  of	  Vibrio	  cholerae,	  which	  induces	  diarrhea,	  thereby	  enhancing	  bacterial	  transmission	  (155).	  	  In	  other	  examples,	  such	  as	  Shiga	  toxin	  expressed	  by	  enterohemorrhagic	  	  Escherichia	  coli	  and	  diphtheria	  toxin	  expressed	  by	  Corynebacterium	  diptheriae,	  phage-­‐encoded	  toxins	  appear	  to	  contribute	  to	  bacterial	  survival	  by	  disrupting	  the	  function	  of	  mammalian	  cells	  involved	  in	  defense	  (54,	  114).	  	  Phages	  also	  affect	  their	  bacterial	  hosts	  in	  many	  other	  ways.	  Phages	  can	  serve	  as	  gene	  shuttles	  providing	  access	  to	  a	  “pool	  of	  diversity”	  for	  bacteria	  inhabiting	  environments	  containing	  other	  members	  of	  the	  same	  or	  related	  species.	  	  These	  beneficial	  effects	  of	  phage	  need	  to	  be	  balanced	  with	  their	  potential	  adverse	  effects,	  such	  as	  bacterial	  lysis.	  	  Phage-­‐mediated	  lysis,	  however,	  may	  benefit	  one	  strain	  through	  niche	  clearance	  if	  it	  acts	  on	  competing	  susceptible	  members	  of	  the	  same	  species	  or	  other	  constituents	  of	  the	  microflora.	  While	  the	  phages	  of	  many	  important	  bacterial	  species	  have	  been	  investigated	  in	  detail	  in	  regards	  to	  their	  structure,	  invasion,	  gene	  regulation,	  and	  other	  characteristics,	  here	  we	  will	  review	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specifically	  those	  studies	  that	  examined	  the	  impact	  of	  phages	  on	  bacterial	  species	  during	  mammalian	  colonization	  or	  the	  pathogenesis	  of	  disease.	  	  	  Phages	  that	  impact	  their	  bacterial	  hosts	  in	  a	  positive	  way	  are	  temperate.	  	  Temperate	  phages	  can	  enter	  either	  the	  lysogenic	  or	  lytic	  pathway	  after	  invasion	  of	  the	  bacterium.	  	  The	  lytic	  pathway	  involves	  the	  normal	  production	  of	  phage	  DNA	  and	  proteins	  to	  make	  new	  phage	  and	  subsequently	  lyse	  the	  cell.	  	  The	  lysogenic	  pathway	  leads	  to	  phage	  integration	  into	  the	  bacterial	  genome.	  	  In	  this	  stage,	  the	  integrated	  phage	  is	  called	  a	  prophage	  while	  the	  bacterial	  host	  is	  called	  a	  lysogen.	  	  Prophages	  usually	  express	  a	  set	  of	  genes	  to	  maintain	  lysogeny,	  while	  the	  rest	  of	  the	  genes	  are	  repressed.	  However,	  some	  phages	  have	  been	  found	  to	  express	  additional	  genes	  that	  affect	  the	  biology	  of	  their	  host	  bacteria.	  Classically,	  when	  the	  bacterium	  experiences	  stress,	  the	  SOS	  response	  leads	  to	  an	  increase	  in	  production	  of	  bacterial	  proteases.	  	  The	  proteases	  cleave	  the	  C1	  repressor,	  which	  maintains	  the	  lysogenic	  state	  of	  the	  phage.	  	  Without	  the	  C1	  repressor	  the	  prophage	  is	  reactivated.	  	  During	  reactivation,	  the	  prophage	  is	  excised	  from	  the	  genome	  and	  enters	  the	  lytic	  cycle.	  Temperate	  phages	  can	  impact	  host	  fitness	  at	  many	  stages	  of	  the	  phage	  lifecycle.	  	  	  We	  have	  chosen	  to	  limit	  our	  discussion	  to	  phages	  of	  the	  clinically	  and	  agriculturally	  important	  genus	  of	  Streptococcus,	  and	  a	  few	  closely	  related	  relatives,	  in	  order	  to	  discuss	  in	  more	  detail	  the	  diverse	  mechanisms	  by	  which	  phage	  impact	  bacterial-­‐mammalian	  host	  interactions	  (summarized	  in	  Figure	  1).	  The	  bacterial	  species	  that	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make	  up	  this	  genus,	  despite	  being	  closely	  related,	  are	  found	  in	  diverse	  environments	  and	  perform	  a	  large	  set	  of	  functions.	  	  Many	  streptococcal	  species	  are	  human	  pathogens	  with	  a	  clear	  impact	  on	  human	  health,	  including	  S.	  pyogenes,	  and	  S.	  
pneumoniae	  as	  well	  as	  the	  closely	  related	  genus	  Enterococcus,	  which	  includes	  E.	  
faecalis	  and	  E.	  faecium.	  	  Animal	  pathogens,	  such	  as	  S.	  equi	  sp.	  and	  S.	  suis,	  have	  a	  significant	  impact	  on	  the	  farm	  animal	  industry.	  Others	  species	  largely	  colonize	  humans	  and	  animals	  and	  only	  occasionally	  cause	  disease,	  including	  S.	  mitis,	  S.	  oralis	  and	  S.	  mutans.	  	  Still	  others,	  such	  as	  S.	  thermophilus,	  are	  used	  extensively	  in	  industrial	  processes,	  such	  as	  cheese	  production.	  With	  so	  many	  species	  in	  this	  genus	  that	  affect	  human	  welfare	  in	  a	  number	  of	  ways,	  it	  is	  important	  to	  study	  the	  relationships	  between	  the	  streptococci	  and	  factors	  that	  impact	  their	  fitness.	  	  New	  virulent	  and	  temperate	  phages	  are	  continually	  being	  discovered	  for	  streptococcal	  and	  enterococcal	  species.	  Dozens	  of	  these	  phage	  genomes	  have	  been	  sequenced	  and	  characterized.	  The	  frequency	  of	  lysogenized	  isolates	  is	  high	  amongst	  many	  streptococcal	  species.	  	  For	  S.	  pneumoniae,	  it	  has	  been	  estimated	  up	  to	  70%	  of	  clinical	  isolates	  are	  lysogenized(122).	  	  S.	  pyogenes	  is	  almost	  always	  lysogenized	  or	  poly-­‐lysogenized,	  with	  studies	  showing	  that	  the	  most	  virulent	  strains	  have	  acquired	  multiple	  phages	  over	  the	  years(135,	  139,	  141).	  	  Other	  streptococcal	  species	  are	  less	  well	  studied	  epidemiologically	  but	  are	  likely	  to	  have	  similar	  rates	  of	  lysogeny.	  Morphologically,	  the	  majority	  of	  phages	  that	  infect	  this	  genus	  are	  tailed,	  siphoviridae,	  podoviridae	  and	  myoviridae(2).	  A	  few	  non-­‐tailed	  phages	  have	  been	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Phage-­mediated	  horizontal	  gene	  transfer	  In	  order	  to	  adapt	  to	  a	  changing	  host	  environment,	  it	  is	  beneficial	  for	  bacteria	  to	  have	  access	  to	  a	  pool	  of	  genetic	  material	  to	  promote	  diversity.	  The	  genetic	  determinants	  of	  host	  specificity	  in	  streptococci,	  for	  example,	  can	  be	  very	  small	  and	  often	  come	  down	  to	  just	  a	  small	  subset	  of	  genes	  which	  can	  easily	  be	  attributed	  to	  horizontal	  gene	  transfer	  or	  lysogenic	  conversion	  (73).	  	  As	  is	  the	  case	  for	  other	  bacterial	  genera,	  members	  of	  Streptococcus	  have	  many	  phages	  that	  contribute	  to	  diversity	  via	  transduction	  of	  virulence	  genes	  and	  antibiotic	  resistance	  cassettes	  both	  within	  and	  across	  bacterial	  species	  (47).	  Evidence	  of	  phage-­‐mediated	  horizontal	  gene	  transfer	  and	  lysogenic	  conversion	  within	  and	  between	  species	  has	  been	  largely	  indirect,	  consisting	  of	  sequencing	  and	  analysis	  of	  homologous	  phages	  within	  their	  bacterial	  hosts	  and	  experimental	  demonstration	  of	  cross-­‐species	  infective	  phages.	  	  	  The	  genomic	  and	  experimental	  evidence	  of	  phage-­‐generated	  diversity	  within	  streptococcal	  species	  has	  been	  well	  studied	  and	  reviewed	  (33,	  55,	  143,	  152).	  	  Phages	  that	  infect	  S.	  pyogenes,	  for	  instance,	  contribute	  to	  the	  diversification	  of	  the	  species	  by	  transducing	  the	  genes	  for	  toxins,	  such	  as	  superantigens,	  and	  virulence	  factors,	  such	  as	  hyaluronidases,	  which	  we	  will	  cover	  later	  in	  this	  review.	  (78,	  167)	  It	  has	  also	  been	  shown	  that	  for	  S.	  pneumoniae	  serotype	  1,	  variations	  in	  virulence	  in	  a	  mouse	  model	  of	  infection	  can	  be	  attributed	  to	  a	  few	  highly	  variable	  genomic	  regions,	  one	  of	  which	  is	  a	  prophage	  (67).	  Phages	  of	  S.	  pneumoniae	  also	  harbor	  a	  homologue	  of	  the	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bacterial	  virulence	  factor	  LytA,	  indicating	  genomic	  rearrangements	  between	  the	  prophage	  and	  bacterial	  genome	  (109).	  In	  each	  of	  these	  examples,	  phage	  is	  contributing	  to	  the	  species	  diversity,	  which	  allows	  the	  bacterial	  hosts	  to	  better	  adapt	  to	  changing	  environments.	  	  There	  is	  also	  considerable	  evidence	  of	  homologous	  phages	  infecting	  different	  species	  of	  streptococci,	  for	  both	  species	  residing	  in	  the	  same	  niche	  and	  across	  niches.	  In	  geographic	  areas	  where	  multiple	  streptococcal	  species	  are	  endemic,	  phages	  originating	  in	  S.	  pyogenes	  not	  only	  provide	  variation	  within	  this	  species	  but	  also	  seem	  to	  have	  crossed	  over	  into	  commensal	  species,	  such	  as	  S.	  dysgalacatiae	  subsp.	  equisimilus,	  a	  group	  C	  Streptococcus.	  (39,	  40)	  Genomic	  studies	  of	  S.	  pyogenes	  suggested	  over	  90	  phage-­‐associated	  horizontal	  gene	  transfer	  events	  originating	  from	  several	  zoonotic	  species,	  including	  S.	  equi,	  S.	  dysgalactiae	  and	  S.	  canis.	  (88)	  S.	  
equi	  was	  observed	  to	  have	  the	  greatest	  number	  of	  genetic	  exchange	  events	  with	  S.	  
pyogenes,	  despite	  the	  fact	  that	  S.	  equi	  is	  an	  obligate	  horse	  pathogen	  while	  S.	  pyogenes	  is	  uniquely	  adapted	  to	  human	  hosts.	  Three	  phage	  encoded	  superantigens	  that	  define	  the	  emergence	  of	  a	  particularly	  virulent	  strain	  of	  S.	  pyogenes	  (M3)	  were	  also	  identified	  in	  phages	  of	  S.	  equi	  that	  predate	  the	  emergence	  of	  M3	  (73).	  Conversely,	  the	  toxins	  SpeH	  and	  SpeI	  were	  recently	  acquired	  in	  S.	  equi	  and	  likely	  originated	  from	  
S.	  pyogenes.	  Both	  examples	  indicate	  a	  common	  phage	  pool	  leading	  shared	  virulence	  factors	  between	  the	  two	  species.	  In	  another	  study,	  phages	  of	  each	  of	  the	  species	  S.	  
pyogenes,	  Lactococcus	  lactis	  and	  S.	  thermophilus	  have	  been	  sequenced	  and	  show	  a	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close	  phylogenetic	  relationship	  implicating	  a	  potential	  shared	  pool	  of	  cross-­‐reactive	  phages	  infecting	  both	  human	  pathogens	  and	  species	  relevant	  in	  the	  food	  industry	  that	  are	  not	  found	  in	  humans	  (46).	  Although	  these	  studies	  document	  homologous	  phages	  among	  multiple	  species	  from	  different	  environments,	  they	  do	  not	  show	  direct	  evidence	  of	  cross	  infectivity	  in	  vivo.	  	  However,	  these	  observations	  have	  broad	  implications	  for	  how	  the	  bacteria	  that	  humans	  consume	  and	  acquire	  through	  contact	  with	  animals	  may	  affect	  the	  human	  microbiota.	  	  Phages	  of	  streptococci	  have	  been	  implicated	  in	  the	  transfer	  of	  antibiotic	  resistance	  within	  and	  between	  species.	  Antibiotic	  resistance,	  particularly	  in	  prominent	  streptococcal	  species	  that	  infect	  humans,	  including	  S.	  pyogenes	  and	  S.	  pneumoniae,	  has	  become	  a	  serious	  and	  increasing	  public	  health	  issue	  (3,	  149).	  Phages	  have	  been	  shown	  to	  be	  capable	  of	  transducing	  genes	  encoding	  resistance	  to	  commonly	  prescribed	  antibiotics,	  including	  tetracycline,	  chloramphenicol,	  macrolides,	  lincomycin	  and	  clindamycin,	  in	  vitro	  between	  non-­‐clinical	  strains	  of	  S.	  pyogenes	  (148).	  	  Additionally,	  prophages	  have	  been	  detected	  in	  clinical	  isolates	  of	  S.	  pyogenes	  resistant	  to	  erythromycin	  (75).	  By	  inducing	  these	  phages	  and	  infecting	  other	  strains	  of	  S.	  pyogenes,	  it	  was	  determined	  that	  these	  prophages	  carry	  the	  erythromycin	  resistance	  gene.	  	  In	  fact,	  this	  was	  the	  first	  example	  of	  a	  phage	  in	  a	  clinical	  isolate	  found	  to	  carry	  an	  antibiotic	  resistance	  element.	  Erythromycin	  and	  other	  macrolide	  resistance	  are	  due	  to	  an	  efflux	  pump	  encoded	  by	  two	  genes,	  mefA	  and	  msrD.	  One	  of	  these	  genes,	  mefA,	  and	  the	  gene	  responsible	  for	  tetracycline	  resistance,	  tetO,	  were	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identified	  and	  characterized	  on	  the	  S.	  pyogenes	  phage	  Φm46.1	  (48).	  Tetracycline	  resistance,	  encoded	  by	  the	  gene	  tetW,	  has	  also	  been	  reported	  on	  S.	  suis	  phage	  
ϕSsUD.1.	  	  In	  vitro	  ϕSsUD.1	  demonstrates	  cross	  infectivity	  with	  S.	  pyogenes	  indicating	  the	  possibility	  that	  it	  is	  capable	  of	  transducing	  antibiotic	  resistance	  between	  bacterial	  species	  inhabiting	  different	  hosts	  (117).	  	  Although	  much	  of	  the	  best	  evidence	  for	  horizontal	  gene	  transfer	  amongst	  streptococci	  comes	  from	  metagenomic	  sequencing	  studies,	  there	  have	  been	  experimental	  demonstrations	  of	  cross	  reactive	  phage	  between	  group	  A	  and	  group	  C	  streptococci	  (157).	  In	  this	  study,	  phages	  that	  were	  induced	  and	  propagated	  on	  group	  A	  streptococci	  were	  able	  to	  plaque	  with	  consistently	  high	  titer	  on	  several	  group	  C	  streptococcal	  indicator	  strains.	  Conversely,	  phages	  induced	  from	  group	  C	  streptococci	  also	  formed	  plaques	  on	  group	  A	  streptococcal	  indicator	  strains,	  though	  to	  a	  lesser	  degree.	  Lastly,	  movement	  by	  transduction	  of	  streptomycin	  and	  bacitracin	  resistance	  markers	  has	  been	  observed	  by	  these	  same	  cross-­‐reactive	  phages.	  A	  more	  recent	  study	  also	  showed	  that	  phage	  149,	  isolated	  from	  an	  M2	  isolate	  of	  S.	  pyogenes,	  was	  able	  to	  infect	  and	  lysogenize	  many	  M-­‐types	  of	  S.	  pyogenes	  as	  well	  as	  the	  species	  
S.	  equi	  (153).	  These	  two	  studies	  provide	  the	  most	  direct	  evidence	  of	  phage-­‐mediated	  gene	  transfer	  between	  different	  species	  of	  streptococci	  and	  highlight	  the	  potential	  of	  phages	  to	  be	  a	  mode	  of	  transfer	  for	  the	  substantial	  genetic	  diversity	  found	  in	  numerous	  streptococcal	  and	  related	  species.	  	  
	  
41	  
Phage-­encoded	  virulence	  factors	  The	  contribution	  of	  bacteriophage	  to	  bacterial	  fitness	  in	  vivo	  is	  largely	  dependent	  on	  the	  expression	  of	  phage	  encoded	  virulence	  factors.	  These	  virulence	  factors	  are	  well	  known	  to	  account	  for	  much	  of	  the	  strain	  to	  strain	  variation	  in	  pathogenicity,	  particularly	  in	  group	  A	  streptococci	  but	  also	  in	  other	  streptococcal	  species,	  and	  may	  be	  a	  determining	  factor	  in	  clinical	  outcomes	  (33,	  55,	  152).	  Phage	  encoded	  virulence	  factors	  include	  toxins	  that	  directly	  cause	  damage	  to	  the	  host	  (e.g.,	  superantigens),	  enzymes	  acting	  on	  mammalian	  cell	  processes,	  (e.g.,	  	  phospholipases),	  or	  immune	  evading	  factors	  (e.g.,	  DNases).	  The	  general	  topic	  of	  phage	  encoded	  exotoxins	  has	  been	  reviewed	  in	  detail	  elsewhere	  (32).	  Examples	  of	  each	  of	  these	  categories	  of	  phage-­‐encoded	  virulence	  factors	  are	  provided	  below.	  	  Superantigens	  cause	  an	  influx	  and	  non-­‐clonal	  activation	  of	  T-­‐cells	  leading	  to	  a	  cytokine	  storm	  and	  are	  responsible	  for	  much	  of	  the	  pathogenicity	  of	  group	  A	  streptococci	  (10).	  These	  virulence	  factors	  consist	  of	  streptococcal	  pyrogenic	  exotoxins,	  SpeA,	  C	  and	  H	  to	  M,	  which	  are	  exclusively	  found	  on	  phage	  genomes	  (138).	  	  Other	  superantigens	  such	  as	  mitogenic	  factors	  3	  and	  4	  (mf3,	  mf4)	  and	  Streptococcal	  Super	  Antigen	  (SSA)	  have	  been	  found	  on	  prophages	  in	  the	  particularly	  virulent	  M3	  clone	  of	  S.	  pyogenes	  and	  have	  been	  determined	  to	  enhance	  virulence	  in	  a	  mouse	  model	  (16).	  Phages	  have	  been	  largely	  responsible	  for	  dissemination	  of	  these	  superantigens	  to	  other	  species	  of	  streptococci,	  including	  S	  dysgalactiae,	  S.	  canis	  and	  
S.	  equi	  (73,	  79,	  158)	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  Phosphlipases,	  common	  component	  of	  snake	  venoms,	  break	  down	  fatty	  acids	  to	  release	  arachidonic	  acid,	  thus	  causing	  host	  tissue	  damage.	  	  A	  recently	  emerged	  M3	  strain	  of	  S.	  pyogenes	  was	  found	  to	  have	  acquired	  a	  phospholipase	  homologue,	  SlaA,	  by	  acquisition	  of	  a	  prophage	  (135).	  	  It	  was	  further	  determined	  that	  SlaA	  was	  induced	  by	  contact	  with	  human	  saliva.	  Mutants	  lacking	  SlaA	  had	  decreased	  adherence	  to	  a	  human	  cell	  line	  and	  decreased	  virulence	  in	  a	  mouse	  model.	  SlaA	  and	  another	  putative	  phospholipase,	  SlaB,	  were	  also	  identified	  in	  infectious	  equine	  isolates	  of	  S.	  equi	  and	  S.	  zooepidemicus	  (73,	  124).	  	  In	  this	  case,	  SlaA	  was	  encoded	  on	  an	  active	  prophage	  while	  SlaB	  was	  found	  within	  a	  prophage	  remnant	  in	  all	  strains.	  Some	  of	  these	  strains	  predate	  the	  emergence	  of	  the	  expression	  of	  SlaA	  by	  S.	  
pyogenes,	  indicating	  the	  M3	  clone	  may	  have	  acquired	  SlaA	  from	  phages	  of	  S.equi	  or	  S.	  
zooepidemicus.	  (73)	  	  Other	  relevant	  virulence	  determinants	  include	  the	  DNases,	  Spd-­‐1,	  Sda1	  and	  SdaD	  (23,	  141).	  	  The	  most	  common	  of	  these	  DNases,	  Sda1,	  was	  shown	  to	  be	  important	  for	  virulence	  in	  a	  mouse	  cutaneous	  lesion	  model	  (28).	  	  This	  was	  attributed	  to	  degradation	  of	  the	  DNA	  scaffold	  of	  Neutrophil	  Extracellular	  Traps	  (NETS),	  which	  demonstrate	  bactericidal	  activity	  against	  strains	  of	  group	  A	  streptococci	  that	  do	  not	  express	  Sda-­‐1.	  Sda-­‐1	  was	  also	  found	  on	  phages	  in	  bovine	  mastitis	  isolates	  of	  S.	  
dysgalactiae	  subsp	  dysgalactiae	  (124)	  and	  on	  a	  phage	  in	  an	  invasive	  human	  isolate	  of	  S.	  dysgalactiae	  subsp	  equisimilus	  (158).	  In	  both	  instances,	  the	  phages	  were	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thought	  to	  have	  originated	  in	  group	  A	  streptococci.	  	  Lastly,	  there	  are	  some	  phage-­‐encoded	  virulence	  factors	  that	  have	  yet	  to	  be	  ascribed	  to	  a	  specific	  mechanism.	  	  For	  example,	  in	  a	  zebra	  fish	  model	  of	  infection,	  lysogenized	  
S.	  suis	  was	  more	  virulent	  than	  the	  wild-­‐type	  strain	  (144).	  	  However,	  sequencing	  of	  the	  phage	  responsible,	  SMP,	  revealed	  no	  known	  toxin	  or	  virulence	  factor	  (96).	  	  Another	  potential	  virulence	  factor	  with	  an	  incompletely	  understood	  mechanism	  is	  the	  phage-­‐encoded	  LytA	  homologue,	  usually	  annotated	  as	  the	  phage	  lysin,	  which	  is	  present	  in	  almost	  all	  known	  phages	  of	  S.	  pneumoniae	  (127).	  Chromasomally-­‐encoded	  LytA	  is	  a	  cell	  surface	  anchored	  amidase	  responsible	  for	  autolysis	  and	  affects	  virulence	  in	  several	  murine	  models	  of	  pathogenesis	  (18,	  72,	  116).	  The	  mechanism	  of	  LytA’s	  involvement	  in	  vivo	  is	  unclear	  but	  it	  has	  been	  speculated	  that	  LytA’s	  contribution	  to	  shedding	  of	  the	  cell	  wall	  may	  be	  responsible.	  	  The	  role	  of	  the	  homologous	  phage	  lysin	  in	  vivo	  is	  unknown.	  It	  is	  likely	  that	  this	  phage	  lysin	  was	  acquired	  from	  the	  bacterial	  genome	  based	  on	  its	  high	  GC	  content	  and	  ability	  to	  recombine	  with	  the	  bacterial	  LytA	  (109).	  	  The	  phage	  lysin	  is	  also	  functionally	  redundant	  with	  LytA	  during	  the	  final	  stage	  of	  the	  phage	  lytic	  cycle,	  phage	  progeny	  release	  (57).	  Each	  of	  these	  examples	  indicate	  that	  further	  work	  in	  determining	  mechanisms	  for	  the	  potential	  phage-­‐encoded	  virulence	  factors	  of	  many	  streptococcal	  phages	  is	  needed.	  	  	  	  
Effects	  of	  phage	  on	  colonization	  and	  adherence	  
	  
44	  
A	  key	  aspect	  of	  streptococcal	  colonization	  and	  disease	  is	  the	  ability	  to	  adhere	  to	  host	  tissues,	  which	  allows	  the	  bacterium	  to	  establish	  its	  niche	  in	  the	  mammalian	  host.	  Streptococcal	  phages	  have	  been	  shown	  to	  improve	  bacterial	  adherence	  to	  host	  cells	  in	  a	  number	  of	  systems,	  including	  S.	  mitis	  and	  S.	  pneumoniae.	  	  Additionally,	  for	  S	  
pneumoniae,	  phages	  have	  been	  shown	  to	  enhance	  biofilm	  formation,	  which	  is	  thought	  to	  prolong	  bacterial	  survival	  in	  the	  host.	  In	  S.	  pyogenes,	  phage	  may	  also	  increase	  host	  tissue	  invasion.	  In	  each	  of	  these	  examples,	  phages	  increase	  bacterial	  persistence	  at	  the	  site	  of	  infection	  promoting	  both	  phage	  and	  bacterial	  survival	  within	  the	  mammalian	  host.	  	  The	  most	  well	  studied	  phage-­‐encoded	  adherence	  factors	  are	  the	  platelet	  binding	  factors	  A	  and	  B,	  encoded	  by	  S.	  mitis	  phage,	  SM1	  (13).	  These	  proteins	  (PblA/B)	  are	  homologous	  to,	  and	  are	  thought	  to	  function	  primarily	  as,	  phage	  tail	  structural	  components.	  As	  such,	  PblA/B	  are	  expressed	  only	  during	  phage	  induction	  (14).	  	  However,	  these	  proteins	  have	  also	  been	  shown	  to	  increase	  bacterial	  adherence	  to	  platelets,	  which	  could	  be	  important	  in	  colonization	  of	  inflamed	  tissues	  and	  facilitate	  the	  establishment	  of	  infected	  thrombotic	  vegetations	  in	  streptococcal	  endocarditis.	  During	  the	  normal	  phage	  lifecycle,	  PblA/B	  are	  released	  when	  holins	  permeabilize	  the	  cell	  membrane	  for	  lysis	  (107).	  Once	  released	  from	  the	  bacterium,	  the	  choline	  binding	  motif	  on	  these	  proteins	  will	  bind	  to	  choline	  residues	  on	  the	  cell	  wall	  and	  are	  displayed	  on	  the	  bacterial	  cell	  surface.	  	  At	  this	  point,	  PblA/B	  is	  able	  to	  bind	  to	  sialic	  acid	  motifs	  on	  platelet	  gangliosides	  (108).	  	  Similarly,	  the	  phage	  lysin	  of	  SM1	  has	  also	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been	  shown	  to	  be	  a	  choline	  binding	  protein	  that	  can	  adhere	  to	  fibrinogen	  domains	  on	  the	  surface	  of	  platelets	  (133).	  Thus,	  by	  bridging	  bacterial	  and	  host	  cells,	  PblA/B	  and	  lysin	  are	  thought	  to	  improve	  bacterial	  adherence.	  It	  is	  assumed	  in	  this	  model	  that	  only	  a	  portion	  of	  the	  population	  of	  bacteria	  is	  lysed	  by	  the	  phage,	  thus	  improving	  adherence	  in	  the	  remaining	  population.	  The	  presence	  of	  PblA/B	  and	  lysin	  and	  subsequent	  increased	  adherence	  to	  platelets	  has	  been	  correlated	  with	  enhanced	  virulence	  of	  S.	  mitis	  in	  a	  rat	  endocarditis	  model.	  	  For	  the	  airway	  pathogen	  S.	  pneumoniae,	  lysogeny	  by	  the	  phage	  MM1	  increases	  adherence	  to	  A549	  respiratory	  tract	  epithelial	  cells	  in	  culture	  (92).	  The	  MM1	  prophage	  is	  also	  correlated	  with	  a	  shift	  in	  bacterial	  phenotype,	  which	  is	  detected	  as	  a	  more	  transparent	  colony	  morphology.	  	  The	  transparent	  phenotype	  has	  been	  previously	  shown	  to	  express	  less	  capsular	  polysaccharide	  per	  cell	  and,	  thereby,	  allow	  for	  increased	  display	  of	  adhesins	  on	  the	  cell	  surface,	  enabling	  stronger	  binding	  to	  host	  cells	  (82,	  161).	  Phase	  variants	  with	  transparent	  colony	  morphology	  have	  previously	  been	  shown	  to	  colonize	  the	  mucosal	  surface	  more	  efficiently	  than	  more	  opaque	  forms.	  	  The	  mechanism	  for	  the	  effect	  of	  MM1	  phage	  on	  colony	  phenotype	  and	  corresponding	  increased	  adherence	  in	  cell	  culture	  is	  unknown.	  	  Although	  many	  types	  of	  phage	  lysogenizing	  S.	  pneumoniae	  have	  been	  described,	  the	  in	  vivo	  relevance	  of	  phage	  for	  persistence	  and	  for	  colonization	  by	  this	  species	  has	  not	  yet	  been	  addressed	  (92).	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Biofilms	  are	  often	  associated	  with	  adherence	  to	  surfaces	  in	  many	  species	  of	  bacteria.	  For	  example,	  in	  the	  pneumococcus,	  biofilms	  have	  been	  shown	  to	  occur	  in	  otitis	  media	  models	  (166).	  	  Pneumococcal	  biofilms,	  which	  are	  thought	  to	  increase	  bacterial	  persistence,	  require	  DNA	  as	  a	  component	  of	  the	  extracellular	  matrix.	  	  By	  lysing	  a	  small	  portion	  of	  the	  bacterial	  population,	  phages	  provide	  a	  source	  of	  exogenous	  DNA,	  which	  serves	  to	  augment	  biofilm	  thickness	  (30).	  	  Phage-­‐enhanced	  biofilm	  formation	  has	  been	  demonstrated	  with	  the	  temperate	  phage	  SV-­‐1	  but	  could	  be	  applicable	  to	  all	  temperate	  phages	  of	  the	  pneumococcus	  and	  potentially	  other	  bacteria.	  By	  enhancing	  biofilm	  formation,	  SV-­‐1	  could	  be	  improving	  bacterial	  persistence	  and	  survival	  in	  the	  middle	  ear	  during	  otitis	  media	  infections.	  However,	  a	  direct	  role	  for	  phage-­‐mediated	  biofilm	  formation	  in	  virulence	  in	  an	  otitis	  media	  model	  has	  not	  yet	  been	  demonstrated.	  	  Phages	  infecting	  S.	  pyogenes	  have	  been	  shown	  to	  encode	  hyaluronan	  lyases	  (76).	  There	  is	  a	  significant	  amount	  of	  hyaluronan	  in	  the	  extracellular	  matrix	  of	  the	  human	  epithelial	  surface	  colonized	  by	  the	  organism.	  	  There	  is	  a	  correlation	  between	  bacteria	  that	  can	  produce	  hyaluronidases	  and	  disease	  (77).	  Breakdown	  of	  the	  hyaluronan	  allows	  the	  bacteria	  to	  invade	  the	  epithelium	  and	  access	  additional	  tissues	  for	  binding.	  	  It	  is	  likely	  that	  S.	  pyogenes	  phage,	  such	  as	  H4489,	  encode	  these	  enzymes	  primarily	  to	  break	  down	  the	  hyaluronan	  which	  is	  also	  found	  in	  the	  capsule	  of	  S.	  pyogenes	  in	  order	  to	  gain	  access	  to	  the	  bacterial	  cell	  for	  infection.	  However,	  antibodies	  to	  the	  phage	  encoded	  hyaluronan	  lyase	  have	  been	  found	  following	  S.	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pyogenes	  infection,	  indicating	  that	  these	  enzymes	  are	  being	  released	  in	  vivo	  (64).	  It	  is	  plausible,	  therefore,	  that	  the	  hyaluronan	  lyase	  also	  assists	  with	  breakdown	  of	  the	  host	  hyaluronan,	  although	  there	  has	  been	  no	  direct	  demonstration	  of	  this	  possibility.	  	  
Phage-­mediated	  competition	  An	  evolving	  story	  is	  that	  of	  the	  involvement	  of	  phage	  in	  competition	  between	  bacterial	  species.	  When	  colonizing	  a	  niche,	  microbes	  must	  compete	  for	  limited	  space	  and	  resources.	  Bacteria	  use	  various	  means	  to	  achieve	  a	  competitive	  advantage	  over	  microbes	  of	  the	  same	  and	  different	  species.	  One	  mechanism,	  recently	  shown	  in	  studies	  performed	  with	  E.	  coli	  and	  E.	  faecalis,	  is	  that	  phage	  can	  be	  used	  as	  a	  lytic	  weapon	  against	  phage-­‐sensitive	  competing	  bacteria	  (24,	  52).	  Streptococcal	  phage	  that	  cross-­‐infect	  between	  species	  could	  be	  mediators	  of	  this	  competition	  by	  the	  same	  mechanism	  described.	  The	  high	  prevalence	  of	  co-­‐colonization	  by	  multiple	  strains	  or	  species	  in	  the	  oropharynx	  and	  incidences	  of	  cross-­‐reactive	  phages	  indicate	  this	  could	  also	  occur	  among	  streptococci.	  There	  is	  also	  evidence	  of	  a	  role	  for	  prophages	  and	  phage	  lysins	  in	  competition	  between	  streptococci	  and	  other	  bacterial	  genera.	  	  The	  direct	  effect	  of	  phage-­‐mediated	  competition	  occurs	  between	  a	  lysogenic	  population	  and	  a	  competitor(s)	  that	  is	  susceptible	  to	  phage	  lysis.	  A	  portion	  of	  lysogenic	  populations	  of	  bacteria	  will	  spontaneously	  lyse,	  thus	  releasing	  phages	  at	  a	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low	  level,	  while	  the	  rest	  of	  the	  lysogenic	  population	  is	  immune	  to	  these	  phages	  due	  to	  phage	  immunity	  islands	  encoded	  by	  the	  prophage	  itself.	  	  However,	  released	  phages	  can	  infect	  and,	  by	  undergoing	  the	  lytic	  pathway,	  kill	  competing	  bacterial	  strains	  that	  are	  not	  lysogens.	  	  Temperate	  phages	  used	  in	  this	  strategy	  are	  more	  successful	  when	  they	  have	  an	  intrinsically	  low	  rate	  of	  entering	  the	  lysogenic	  pathway.	  This	  was	  first	  modeled	  mathematically	  and	  then	  demonstrated	  in	  E.	  coli	  using	  an	  in	  vitro	  system	  (24).	  	  Both	  the	  model	  and	  the	  in	  vitro	  data	  showed	  phage-­‐mediated	  predation	  to	  be	  an	  effective	  strategy	  for	  competing	  bacteria.	  	  More	  recently,	  phage-­‐mediated	  competition	  was	  shown	  to	  occur	  in	  vivo	  using	  E.	  faecalis	  ,	  a	  close	  relative	  of	  the	  streptococci,	  in	  a	  mouse	  gastritis	  model.	  	  In	  this	  study	  E.	  faecalis	  strains	  carrying	  the	  prophage	  competed	  more	  effectively	  against	  susceptible,	  non-­‐lysogenic	  E.	  faecalis	  strains.	  When	  the	  competing	  strains	  were	  both	  lysogens	  the	  competitive	  advantage	  of	  the	  first	  strain	  was	  diminished	  due	  to	  resistance	  to	  phage	  infection	  in	  both	  strains.	  Competition	  was	  also	  less	  effective	  if	  the	  prophage	  on	  the	  first	  strain	  was	  rendered	  inactive.	  The	  authors	  hypothesized	  that	  the	  prophage	  of	  the	  first	  strain	  was	  lysing	  and	  killing	  the	  second	  strain	  of	  E.	  faecalis	  (52).	  	  There	  are	  many	  examples	  of	  simultaneous	  colonization	  or	  infection	  by	  multiple	  strains	  of	  the	  same	  streptococcal	  species	  (26)	  and	  different	  streptococcal	  species	  (89)	  occupying	  the	  same	  niche.	  	  As	  noted	  above,	  there	  are	  phage	  that	  cross	  infect	  between	  streptococcal	  species	  (129,	  157).	  	  Although	  there	  should	  be	  ample	  opportunity	  for	  streptococcal	  phage	  to	  confer	  a	  competitive	  advantage	  by	  this	  mechanism,	  phage-­‐mediated	  competition	  among	  streptococci	  has	  not	  yet	  been	  demonstrated.	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  Lastly,	  phage	  may	  also	  be	  involved	  in	  competition	  between	  streptococci	  and	  other	  bacterial	  species.	  	  Studies	  have	  shown	  that	  certain	  phage	  lysins	  have	  broad	  antibacterial	  activity	  and	  can	  affect	  multiple	  strains	  across	  several	  genera	  of	  bacteria	  including	  most	  streptococci,	  staphylococci,	  listeria	  and	  enterococcus	  (59).	  	  This	  was	  shown	  by	  the	  addition	  of	  purified	  phage	  lysin,	  PlySs2	  from	  an	  S.	  suis	  phage,	  to	  in	  vitro	  cultures.	  Intraperitoneal	  injections	  of	  PlySs2	  were	  also	  able	  to	  clear	  infection	  in	  92%	  of	  mice	  in	  a	  bacteremic	  model	  of	  co-­‐infection	  by	  S.	  aureus	  and	  
S.pyogenes.	  No	  activity	  was	  seen	  against	  gram-­‐negative	  bacteria.	  Purified	  phage	  lysins	  are	  not	  a	  good	  model	  of	  how	  phage	  lysins	  might	  act	  during	  the	  natural	  phage	  cycle.	  Further	  work	  is	  required	  to	  determine	  if	  these	  lysins	  can	  affect	  multiple	  species	  when	  contained	  within	  a	  phage.	  An	  alternative	  mechanism	  of	  competition	  is	  to	  activate	  prophages	  of	  other	  species	  by	  inducing	  bacterial	  hosts’	  stress	  responses.	  	  This	  was	  demonstrated	  in	  competition	  between	  S.	  pneumoniae	  and	  Staphylococcus	  
aureus,	  two	  species	  previously	  demonstrated	  to	  have	  an	  inversely	  correlated	  presence	  during	  natural	  colonization	  (21).	  In	  this	  example,	  the	  production	  of	  high	  levels	  of	  hydrogen	  peroxide	  by	  the	  metabolism	  of	  S.	  pneumoniae	  did	  not	  directly	  damage	  S.	  aureus	  via	  oxidation	  but	  rather	  induced	  an	  SOS	  response	  in	  S.	  aureus	  that	  lead	  to	  a	  loss	  of	  the	  repression	  of	  prophages	  harbored	  in	  its	  genome,	  thus	  activating	  the	  lytic	  cycle	  of	  the	  phage	  (132).	  In	  vitro	  this	  activation	  leads	  to	  lysis	  of	  S.	  aureus	  –	  an	  effect	  that	  could	  presumably	  increase	  niche	  space	  for	  S.	  pneumoniae.	  	  However,	  this	  S.	  pneumoniae-­‐induced	  effect	  of	  phage	  activation	  in	  S.	  aureus	  lysogens	  has	  not	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been	  demonstrated	  in	  vivo.	  	  
Conclusion	  Bacteriophages	  are	  parasites	  of	  the	  microbial	  world,	  only	  able	  to	  live	  and	  replicate	  within	  a	  host	  bacterium.	  	  Though	  little	  work	  has	  been	  done	  to	  characterize	  the	  detrimental	  effects	  of	  prophage	  carriage	  on	  the	  bacterial	  host	  in	  vivo,	  the	  possible	  negative	  effects	  of	  temperate	  phages	  include	  low	  levels	  of	  lysis	  within	  the	  population,	  protein	  and	  DNA	  synthesis	  burden	  and	  interruption	  of	  neighboring	  bacterial	  genes.	  	  Theoretically,	  these	  negative	  effects	  on	  bacterial	  physiology	  must	  be	  overcome	  if	  the	  phage	  is	  to	  maintain	  a	  relationship	  with	  its	  host	  bacterium.	  By	  providing	  a	  benefit	  to	  the	  host	  bacterium	  in	  its	  natural	  environment,	  a	  phage	  can	  overcome	  any	  fitness	  defect	  it	  may	  innately	  cause.	  The	  genetic	  mobility	  of	  phages	  allows	  these	  fitness	  and	  virulence	  factors	  to	  move	  across	  species,	  creating	  a	  reservoir	  of	  genetic	  diversity	  to	  possibly	  create	  new	  pathogens,	  similar	  to	  what	  has	  been	  shown	  in	  marine	  phages	  (31).	  	  We	  have	  highlighted	  a	  few	  strategies	  employed	  by	  the	  phages	  of	  streptococci	  that	  improve	  bacterial	  fitness	  within	  mammalian	  hosts.	  The	  implications	  of	  phage	  encoded	  fitness	  advantages	  include	  changes	  in	  bacterial	  virulence,	  adaptation	  and	  host	  specificity	  and	  are	  relevant	  in	  clinical,	  veterinary	  and	  agricultural	  settings.	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Table	  1.	  The	  effects	  of	  temperate	  phage	  on	  the	  fitness	  of	  Streptococci	  
Phenotypic	  effect	   Species	   Phage	   Mechanism	   Ref	  Adherence	   S.	  mitis	   SM1	   Platelet	  binding	  proteins	  A/B	   (14)	  	   S.	  pneumoniae	   MM1	   Unknown,	  possibly	  increased	  adherence	  due	  to	  transparent	  morphology	   (92)	  	   S.	  pneumoniae	   SV1	   Biofilm	  formation	  due	  to	  excess	  extracellular	  DNA	   (30)	  	   S.	  pyogenes	   All	   Hyaluronidases	  breakdown	  the	  extracellular	  matrix	  allowing	  bacterial	  access	  to	  epithelium	  
(12)	  
Immune	  Evasion	   S.	  pyogenes,	  	  	  	  	  	  S.	  
agalactaiae,	  S.	  equi	  
Many	   Spe	  family	  and	  mitogenic	  factors	  recruit	  and	  activate	  T	  cells	   (138)	  	   S.	  Pyogenes	   Many	   DNAses	  break	  down	  Neutrophil	  Extracellular	  Traps	   (28)	  Host	  Tissue	  Damage	   S.	  pyogenes,	  S.	  dysgalactaiae,	  S.	  
equi,	  S	  
zooepidemicus	  
Φseq2	   Phospholipases	  (SlaA,	  SlaB)	  lead	  to	  arachidonic	  acid	  from	  breakdown	  of	  fatty	  tissue	  which	  damages	  host	  cells	  
(73,	  124,	  135)	  
Antibiotic	  Resistance	   S.	  pyogenes	   Fm46.1	   mefA,	  tetO	   (48)	  	   S.	  suis	   ϕSsUD.1	  	   tetW	   (117)	  Competition	   S.	  pneumoniae	   CP-­‐1	  and	  others	   Phage	  lysins	  delivered	  exogenously	  can	  lyse	  and	  kill	  competing	  bacteria	   (59)	  	   S.	  aureus	   80α,	  Φ11	   Hydrogen	  peroxide	  from	  
S.pneumoniae	  activates	  prophages	  in	  S.	  aureus	   (132)	  	   E.	  faecalis	   ΦV1,	  ΦV7	   bacteria	  compete	  better	  when	  lysogenized	  against	  unlysogenized	  competititors	   (52)	  	  Increased	  Virulence	  	   S.	  pneumoniae	   All	   Phages	  harbor	  LytA	  homologue,	  bacterial	  LytA	  is	  important	  in	  pathogenesis	   (109,	  116)	  	  	   S.	  suis	   SMP	   Lysogenized	  strains	  show	  increased	  mortality	  in	  zebrafish	  model	   (144)	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Chapter	  3	  	  
Tolerance	  of	  a	  phage	  element	  by	  Streptococccus	  pneumoniae	  leads	  
to	  a	  fitness	  defect	  during	  colonization	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Streptococcus	  pneumoniae,	  or	  the	  pneumococcus,	  is	  a	  gram-­‐positive	  opportunistic	  pathogen	  responsible	  for	  ~1	  million	  deaths	  worldwide	  each	  year	  (168).	  	  Although	  a	  leading	  source	  of	  infection,	  the	  pneumococcus	  is	  most	  commonly	  found	  in	  a	  commensal	  relationship	  with	  its	  human	  host	  (20).	  	  Pneumococcal	  colonization	  is	  characterized	  by	  sequential	  and	  overlapping	  episodes	  that	  each	  last	  for	  days	  to	  months.	  	  Colonizing	  pneumococci	  provide	  the	  reservoir	  of	  organisms	  causing	  disease	  and	  are	  likely	  the	  only	  source	  of	  bacteria	  for	  host-­‐to-­‐host	  transmission	  (162).	  Therefore,	  colonizing	  pneumococci	  are	  likely	  to	  be	  the	  focus	  of	  selective	  pressure	  and	  adaptation	  for	  the	  organism.	  During	  colonization,	  pneumococci	  encounter	  varied	  challenges,	  one	  of	  which	  is	  predation	  by	  bacteriophages.	  Up	  to	  70%	  of	  clinical	  isolates	  of	  S.	  pneumoniae	  harbor	  genetic	  elements	  resembling	  prophages	  based	  on	  the	  presence	  of	  the	  phage-­‐encoded	  lysin,	  which	  is	  a	  homologue	  of	  the	  chromosomally-­‐encoded	  cell	  wall	  amidase,	  LytA	  (122).	  How	  these	  prophage	  elements	  affect	  the	  physiology	  of	  their	  pneumococcal	  host	  during	  colonization	  has	  not	  been	  fully	  explored.	  	  The	  predator-­‐prey	  dynamic	  between	  phages	  and	  the	  bacteria	  they	  infect	  has	  been	  an	  important	  factor	  driving	  bacterial	  evolution	  (160).	  	  This	  arms	  race	  has	  resulted	  in	  the	  evolution	  of	  phages	  that	  promote	  the	  fitness	  of	  their	  bacterial	  host,	  including	  its	  survival	  within	  a	  mammalian	  host	  and	  ability	  to	  cause	  disease	  (27).	  	  For	  example,	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prophages	  may	  encode	  toxins	  or	  other	  virulence	  factors	  that	  increase	  the	  ability	  of	  their	  bacterial	  host	  to	  persist	  during	  infection.	  	  Phages	  may	  also	  impact	  genetic	  diversity	  within	  a	  species	  through	  lysogenic	  conversion	  or	  horizontal	  gene	  transfer,	  which	  facilitates	  bacterial	  adaptation	  to	  the	  host	  environment	  (e.g.	  antibiotic	  resistance)(148).	  	  	  In	  contrast	  to	  the	  positive	  effects	  of	  phages	  on	  bacterial	  pathogenesis,	  few	  studies	  have	  assessed	  the	  negative	  effect	  of	  phages	  on	  bacterial	  survival	  during	  infection.	  Aspects	  of	  the	  temperate	  phage	  lifecycle	  that	  could	  theoretically	  have	  a	  negative	  impact	  are	  phage	  lysis,	  increased	  burden	  of	  DNA	  and	  protein	  synthesis,	  or	  cis-­‐acting	  effects	  on	  genes	  flanking	  the	  phage	  attachment	  site.	  	  The	  variety	  of	  phage	  resistance	  mechanisms	  employed	  by	  bacteria	  indicates	  that	  negative	  effects	  of	  carrying	  prophage	  may	  be	  a	  significant	  factor	  in	  bacterial	  fitness	  (85).	  	  In	  the	  case	  of	  the	  pneumococcus,	  prophage	  SV-­‐1	  has	  been	  shown	  to	  enhance	  biofilm	  formation	  by	  increasing	  amounts	  of	  extracellular	  DNA(30).	  Similarly,	  pneumococcal	  prophage	  MM1	  has	  been	  shown	  to	  increase	  bacterial	  adherence	  to	  human	  epithelial	  cells	  in	  culture	  (92).	  	  However,	  the	  contribution	  of	  these	  or	  other	  pneumococcal	  phages	  to	  positive	  or	  negative	  effects	  on	  bacterial	  fitness	  in	  vivo	  has	  not	  been	  demonstrated.	  	  Using	  a	  newly	  identified	  prophage,	  Spn1,	  found	  in	  a	  highly	  successful	  pneumococcal	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lineage,	  and	  a	  well-­‐established	  mouse	  model	  (165),	  we	  examined	  how	  the	  prophage	  effects	  S.	  pneumoniae	  during	  colonization.	  The	  bacterial	  isolate	  harboring	  Spn1	  was	  obtained	  from	  a	  human	  challenge	  study	  and	  shown	  to	  be	  fit	  for	  colonizing	  the	  natural	  host	  for	  up	  to	  122	  days	  (101)	  and	  the	  murine	  nasopharynx	  for	  21	  days	  (165).	  	  Here,	  we	  find	  that	  the	  Spn1	  element	  was	  stably	  present	  and	  transcriptionally	  active	  in	  this	  isolate.	  We	  show	  that	  the	  presence	  of	  Spn1	  correlates	  with	  a	  negative	  impact	  on	  bacterial	  fitness	  during	  colonization.	  	  We	  also	  provide	  evidence	  to	  show	  that	  Spn1	  is	  associated	  with	  changes	  in	  the	  cell	  wall	  physiology	  of	  its	  host.	  	  We	  posit	  that	  this	  change	  is	  a	  mechanism	  for	  tolerance	  of	  phage	  products,	  which	  may	  be	  the	  underlying	  cause	  of	  this	  fitness	  defect.	  	  
Materials	  and	  Methods	  	  
Bacterial	  Growth	  Conditions	  Unless	  noted	  otherwise,	  bacteria	  were	  grown	  in	  C+Y	  medium	  pH	  ~6.8	  (86)	  	  without	  shaking	  in	  sealed	  tubes	  at	  37°C.	  	  Growth	  was	  monitored	  via	  absorbance	  readings	  at	  620nm.	  Bacteria	  were	  plated	  on	  blood	  agar	  plates	  or	  tryptic	  soy	  medium	  (TS)	  +	  Catalase	  (4741	  U/plate)	  (Worthington	  Chemicals).	  C+Y	  was	  supplemented	  with	  streptomycin	  (200µg/mL),	  kanamycin	  (500µg/mL),	  erythromycin	  (1µg/mL),	  neomycin	  (5µg/mL),	  or	  spectinomycin	  (200µg/mL)	  where	  indicated.	  	  
Sequencing	  of	  Spn1	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P1121,	  a	  bacterial	  isolate	  from	  a	  human	  challenge	  study	  (Table	  1)	  was	  sequenced	  on	  an	  Illumina	  HiSeq	  and	  de	  novo	  assembled	  using	  CLC’s	  Main	  Workbench	  (CLC	  bio).	  	  Two	  assembled	  contigs	  containing	  prophage	  coding	  regions	  were	  identified	  by	  NCBI’s	  BLAST	  program.	  	  The	  gap	  between	  the	  two	  contigs	  was	  sequenced	  using	  Sanger	  sequencing	  technology.	  	  Once	  the	  sequence	  was	  complete	  the	  genome	  was	  submitted	  to	  RAST	  for	  annotation	  (9).	  	  
RNA	  isolation	  and	  qRT-­PCR	  RNA	  was	  isolated	  using	  the	  TRIzol®	  reagent	  and	  protocol	  (Lifetechnologies)	  with	  modifications.	  Bacteria	  were	  harvested	  at	  mid-­‐log	  phase	  and	  a	  2:1	  volume	  of	  RNAprotect	  Bacteria	  Reagent	  (Qiagen)	  was	  added	  to	  the	  culture.	  	  Bacteria	  were	  then	  resuspended	  in	  TRIzol®,	  frozen	  and	  then	  disrupted	  by	  bead	  beating	  for	  5min.	  RNA	  was	  isolated	  by	  Phenol/chloroform	  extraction	  as	  written	  in	  the	  TRIzol®	  protocol.	  After	  re-­‐suspension	  of	  the	  RNA	  in	  RNase	  free	  water,	  samples	  were	  treated	  with	  Dnase(Qiagen)	  for	  30min	  at	  37°C.	  	  DNase	  was	  inactivated	  at	  65°C	  for	  10min	  before	  RNA	  was	  then	  used	  to	  make	  cDNA.	  	  RT-­‐PCR	  was	  carried	  out	  using	  the	  High-­‐Capacity	  cDNA	  Reverse	  Transcription	  Kit	  (Applied	  Biosystems).	  	  	  Quantitative	  PCR	  was	  performed	  with	  the	  Power	  SYBR	  Green	  PCR	  Mastermix	  (Applied	  Biosystems).	  mRNA	  levels	  were	  quantified	  using	  ΔCT	  values	  and	  compared	  to	  an	  internal	  control,	  
gyrA.	  Primers	  are	  listed	  in	  Table	  2.	  	  
DNAse	  Protection	  Assay	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Supernatants	  from	  cultures	  treated	  or	  untreated	  with	  5µg/mL	  mitomycin	  C	  (Sigma-­‐Aldrich)	  were	  filtered	  through	  a	  .22µm	  syringe	  filter.	  	  Samples	  were	  divided	  and	  treated	  or	  not	  with	  DNAse	  (Qiagen)	  and	  incubated	  for	  30min	  at	  37°C.	  	  DNAse	  was	  then	  inactivated	  at	  65°C	  for	  10min.	  	  DNA	  was	  quantified	  via	  quantitative	  PCR	  using	  the	  Power	  SYBR	  Green	  PCR	  Mastermix	  (Applied	  Biosystems).	  	  
Generation	  of	  Mutants	  Bacterial	  mutants	  were	  created	  in	  the	  P1121	  background	  by	  first	  amplifying	  regions	  upstream	  and	  downstream	  of	  the	  gene	  of	  interest	  via	  PCR.	  For	  each	  mutant,	  a	  set	  of	  primers	  1-­‐6	  was	  designed.	  	  Primers	  amplifying	  the	  flanking	  regions	  are	  designated	  1&2	  (upstream)	  and	  5&6	  (downstream).	  Antibiotic	  cassettes	  were	  amplified	  using	  primers	  3&4.	  PCR	  was	  carried	  out	  using	  standard	  techniques	  with	  either	  Taq	  DNA	  Polymerase	  (Invitrogen)	  and	  related	  reagents	  for	  non-­‐cloning	  related	  PCR	  assays	  or	  Platinum	  Pfx	  Polymerase	  (Invitrogen)	  and	  related	  reagents	  for	  PCR	  related	  to	  cloning.	  Primers	  used	  are	  listed	  in	  Table	  2.	  Primers	  2-­‐5	  were	  tagged	  with	  an	  overlapping	  sequence.	  A	  DNA	  fragment	  was	  then	  created	  using	  overlap-­‐extension	  PCR	  (70)	  with	  the	  amplified	  regions	  flanking	  the	  antibiotic	  resistance	  cassette	  of	  choice.	  Antibiotic	  resistance	  markers	  used	  were	  erythromycin	  resistance,	  Emr	  (pCR2.1-­‐TOPO	  plasmid	  with	  Emr	  insertion	  from	  pMU1328(1)),	  kanamycin	  resistance,	  Knr	  (Janus	  Cassette	  (140)),	  and	  spectinomycin	  resistance,	  Spr	  (pCR2.1-­‐TOPO	  with	  Spr	  insertion	  from	  pBI143	  (aad9,	  GenBank	  accession	  number	  U30830)(136)).	  This	  PCR	  fragment	  was	  transformed	  directly	  into	  bacteria	  using	  a	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transformation	  protocol	  as	  previously	  described(74).	  Mutants	  with	  an	  unmarked	  deletion	  were	  made	  via	  the	  Janus	  Cassette	  as	  previously	  described	  (140).	  Primers	  and	  antibiotic	  cassettes	  used	  for	  each	  mutant	  strain	  are	  listed	  in	  Table	  2.	  Constructs	  were	  confirmed	  by	  sequencing	  across	  junctions.	  	  
Mitomycin	  C	  Assays	  Bacteria	  were	  grown	  to	  mid-­‐log	  phase	  then	  diluted	  to	  an	  OD620	  of	  0.1	  in	  C+Y	  with	  or	  without	  0.5µg/mL	  of	  mitomycin	  C	  (Sigma-­‐Aldrich).	  Growth	  at	  37°C	  without	  shaking	  was	  recorded	  as	  the	  OD620	  over	  4	  hours	  after	  treatment.	  Samples	  were	  collected	  for	  RNA	  isolation	  two	  hours	  after	  addition	  of	  mitomycin	  C.	  Control	  strains	  TIGR4	  (MM1-­‐)	  and	  TIGR4M	  (MM1+)	  were	  obtained	  from	  Dr.	  V.	  Fischetti,	  Rockefeller	  University	  (Table	  1).	  	  
Mouse	  Model	  of	  Colonization	  Bacteria	  were	  grown	  to	  mid-­‐log	  phase	  (OD620	  0.5)	  in	  C+Y	  medium.	  1mL	  of	  culture	  was	  pelleted	  and	  resuspended	  in	  100µL	  of	  PBS.	  	  For	  competitive	  assays	  bacteria	  were	  combined	  in	  a	  1:1	  ratio	  after	  re-­‐suspension.	  10µL	  of	  resuspended	  bacteria	  were	  dropped	  onto	  the	  nostrils	  of	  non-­‐anaesthetized	  wild-­‐type	  female	  C57BL/6	  mice,	  6-­‐8	  weeks	  of	  age.	  Inoculum	  counts	  were	  ~1x106	  CFU/ml.	  	  For	  competitive	  assays,	  at	  least	  50	  colonies	  of	  the	  inoculum	  were	  plated	  to	  determine	  streptomycin	  sensitivity	  or	  resistance	  and	  thereby	  the	  input	  ratio.	  Seven	  days	  after	  inoculation,	  nasal	  lavages	  were	  taken	  as	  previously	  described	  (100)	  and	  plated	  on	  TS	  with	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neomycin	  (5µg/mL)	  to	  determine	  colony	  forming	  units.	  For	  competitive	  assays,	  at	  least	  50	  colonies	  from	  each	  mouse	  were	  tested	  for	  streptomycin	  resistance	  or	  sensitivity	  to	  determine	  an	  output	  ratio.	  	  Competitive	  indices	  were	  calculated	  by	  (output	  ratio)/(input	  ratio).	  Statistics	  were	  calculated	  using	  a	  one	  sample	  T-­‐test	  on	  log	  values	  of	  all	  competitive	  indices	  and	  compared	  to	  a	  hypothetical	  value	  of	  0	  which	  would	  indicate	  no	  competitive	  advantage	  or	  disadvantage.	  	  
In	  vitro	  Competitive	  Growth	  Assay	  Bacterial	  strains	  were	  grown	  up	  to	  OD620	  0.5	  in	  C+Y	  then	  diluted	  to	  OD620	  0.1.	  	  1mL	  of	  each	  strain	  and	  2mL	  of	  fresh	  culture	  for	  a	  total	  of	  4ml	  were	  combined	  to	  start	  the	  assay.	  	  Cultures	  were	  incubated,	  without	  shaking	  at	  37°C	  and	  plated	  for	  bacterial	  counts	  at	  0	  hours	  and	  5	  hours	  on	  selective	  media	  for	  an	  input	  and	  output	  ratio	  respectively	  to	  calculate	  the	  competitive	  index.	  	  
Growth	  and	  Autolysis	  Assays	  Bacteria	  were	  diluted	  from	  mid-­‐log	  phase	  culture	  to	  a	  low	  starting	  OD620	  (~.05)	  and	  grown	  in	  a	  96-­‐well	  plate	  in	  an	  incubating	  plate	  reader	  set	  at	  37°C	  in	  180µl	  C+Y	  medium	  with	  10µl	  of	  catalase	  (30,000U/mL)(Worthington	  Chemicals)	  for	  24	  hours.	  Penicillin	  sensitivity	  was	  determined	  across	  a	  range	  of	  concentration	  from	  10-­‐50ng/ml	  (50ng/mL	  exceeded	  the	  MIC	  for	  both	  strains,	  defined	  as	  total	  inhibition	  of	  growth)	  under	  these	  conditions.	  Absorbance	  at	  600nm	  was	  measured	  every	  15	  minutes	  with	  5	  seconds	  of	  shaking	  on	  a	  low	  setting	  before	  every	  reading.	  Co-­‐
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cultures	  were	  comprised	  of	  100µl	  fresh	  medium	  (Brain	  Heart	  Infusion(BHI))	  and	  50µl	  of	  each	  of	  the	  strains	  grown	  to	  mid	  log	  phase	  and	  diluted	  to	  a	  low	  OD620	  (~.05)	  in	  BHI.	  	  
Western	  Blot	  Whole	  cell	  lysates	  were	  created	  by	  resuspending	  bacteria	  (harvested	  at	  mid-­‐log	  phase)	  in	  loading	  dye	  (30	  mM	  Tris–HCl	  pH	  6.8,	  2%	  SDS,	  10%	  glycerol	  and	  2%	  β-­‐mercaptoethanol)	  and	  incubated	  at	  95°	  for	  5min.	  	  Lysates	  were	  loaded	  onto	  a	  10%	  glycine	  gel	  (Mini-­‐Protean	  TGX	  Gel,	  BioRad)	  and	  run	  under	  standard	  conditions.	  	  Protein	  was	  transferred	  to	  a	  PVDF	  membrane	  via	  a	  semi-­‐dry	  transfer.	  	  After	  transfer,	  the	  membrane	  was	  allowed	  to	  dry,	  blocked	  with	  2%	  BSA	  solution	  in	  phosphate	  buffered	  saline,	  and	  incubated	  with	  1:100	  dilution	  of	  anti-­‐LytA	  Rabbit	  IgG	  (obtained	  from	  Dr.	  R.	  Lopez,	  Biological	  Research	  Center,	  Madrid,	  Spain)	  or	  1:40	  dilution	  of	  anti-­‐pneumolysin	  Mouse	  IgG	  (Novacastra	  Laboratories	  Ltd.,	  Buffalo	  Grove,	  IL)	  for	  two	  hours.	  	  This	  was	  followed	  by	  incubation	  with	  an	  appropriate	  secondary	  antibody	  conjugated	  to	  alkaline	  phosphatase	  (anti-­‐Rabbit	  IgG	  or	  anti-­‐Mouse	  IgG	  respectively,	  diluted	  1:5000	  (Sigma)).	  Proteins	  were	  visualized	  with	  a	  5-­‐bromo-­‐4-­‐chloro-­‐3'-­‐indolyphosphate	  and	  nitro-­‐blue	  tetrazolium	  reaction.	  	  
Microscopy	  Bacteria	  were	  grown	  to	  mid-­‐log	  phase	  in	  C+Y	  medium.	  Samples	  were	  blinded	  before	  images	  at	  400x	  magnification	  were	  taken	  on	  a	  Nikon	  E600	  brightfield	  microscope.	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ImageJ	  analysis	  was	  performed	  using	  the	  “threshold”	  function	  followed	  by	  the	  “analyze	  particles”	  function	  to	  quantify	  particle	  size.	  For	  transmission	  electron	  microscopy,	  samples	  were	  grown	  to	  mid-­‐log	  phase	  then	  pelleted.	  	  Pelleted	  bacteria	  were	  high	  pressure	  frozen,	  freeze	  substituted	  into	  acetone	  with	  2%	  OsO4	  &	  0.1%	  UA,	  embedded	  in	  EPON	  resin,	  cut	  into	  70	  nm	  sections,	  and	  imaged	  on	  JEOL	  1010	  microscope	  at	  X	  mag	  on	  AMT	  1K	  x	  1K	  camera	  	  
Results	  	  
Identification	  of	  Phage	  Element	  Spn1	  	  Phage	  element	  Spn1	  was	  first	  identified	  in	  a	  human	  colonization	  isolate	  of	  
Streptococcus	  pneumoniae	  via	  PCR	  using	  the	  prophage	  typing	  system	  described	  by	  Romero	  et	  al	  (128).	  Subsequent	  sequencing	  of	  the	  entire	  locus	  (43kb)	  revealed	  a	  novel	  phage	  element	  most	  closely	  related	  to	  phage040922	  (GenBank	  accession	  no.	  FR671406.1).	  However,	  the	  integrase	  (int)	  and	  lysin	  (mml)	  of	  Spn1	  shared	  99%	  and	  95%	  identity,	  respectively,	  to	  the	  previously	  characterized	  pneumococcal	  phage	  MM1	  (GenBank	  accession	  no.	  AJ302074.2).	  The	  sequence	  of	  phage	  element	  Spn1	  was	  annotated	  using	  RAST,	  which	  predicted	  63	  open	  reading	  frames.	  Similar	  to	  lambda	  phage,	  the	  genome	  was	  organized	  into	  lytic	  (lysis,	  structural	  and	  replication	  genes)	  and	  lysogenic	  (Figure	  1A)	  functional	  clusters.	  The	  Spn1	  phage	  element	  integrates	  between	  two	  convergently	  transcribed	  genes	  annotated	  as	  SP_1563	  (a	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pyridine-­‐nucleotide-­‐disulpho-­‐oxidoreductase)	  and	  SP_1564	  (conserved	  hypothetical	  protein)	  in	  the	  TIGR4	  genome	  (GenBank	  accession	  no.	  AE005672.3).	  	  The	  attachment	  site	  is	  likely	  to	  be	  the	  same	  attachment	  site	  for	  MM1,	  a	  15	  base	  pair	  sequence	  located	  at	  the	  3’	  end	  of	  the	  coding	  sequence	  for	  SP_1564(Figure	  1B)(60).	  Integration	  of	  Spn1	  does	  not	  interrupt	  the	  coding	  region	  or	  promoter	  sequence	  of	  either	  flanking	  gene.	  Both	  flanking	  genes	  are	  highly	  conserved	  amongst	  published	  S.	  
pneumoniae	  strains.	  	  
Spn1	  activity	  	  We	  designed	  PCR	  primers	  to	  amplify	  across	  the	  attachment	  site	  of	  both	  the	  prophage	  and	  the	  bacteria	  to	  determine	  if	  Spn1	  was	  capable	  of	  excising	  (Table	  2).	  	  Both	  sets	  of	  primers	  amplified	  a	  product	  in	  non-­‐induced	  genomic	  DNA	  samples	  indicating	  a	  background	  level	  of	  spontaneous	  excision	  and	  circularization	  of	  Spn1	  from	  the	  P1121	  genome	  (Figure	  1C).	  	  Using	  qRT-­‐PCR	  on	  bacterial	  RNA	  isolated	  from	  non-­‐induced	  log-­‐phase	  cultures,	  we	  determined	  that	  Spn1	  expresses	  its	  lysogenic	  genes	  as	  expected	  but	  also	  expresses	  lytic	  genes,	  including	  those	  encoding	  its	  lysin	  (Mml)	  and	  holins	  (Figure	  1D).	  Despite	  the	  expression	  of	  lytic	  genes,	  we	  were	  unable	  to	  identify	  plaques	  on	  any	  indicator	  strain	  using	  a	  plaque	  assay	  that	  was	  previously	  described	  for	  S.	  pneumoniae(57).	  	  Additionally,	  there	  was	  no	  evidence	  of	  phage	  particles	  using	  a	  DNAse	  protection	  assay	  or	  in	  transmission	  electron	  micrographs	  of	  strain	  P1121.	  	  A	  selectable	  marker	  was	  inserted	  within	  Spn1	  to	  determine	  whether	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the	  prophage	  could	  be	  cured	  as	  indicated	  by	  loss	  of	  the	  marker	  during	  passage.	  	  No	  Spn1-­‐	  revertants	  were	  identified	  during	  in	  vitro	  growth	  (spontaneous	  cure	  rate	  <.002	  per	  generation).	  Spn1	  was	  then	  removed	  from	  strain	  P1121	  using	  Janus	  cassette	  technology	  to	  generate	  an	  unmarked,	  in-­‐frame	  deletion,	  Spn1-­‐	  (140).	  	  
Spn1	  induction	  by	  mitomycin	  C	  
	  The	  P1121	  lysogen	  was	  treated	  with	  the	  DNA	  crosslinking	  agent	  mitomycin	  C	  (5µg/mL)	  to	  trigger	  the	  SOS	  response	  and	  activate	  the	  Spn1	  prophage.	  	  Mitomycin	  C	  treatment	  of	  strain	  TIGR4	  with	  or	  without	  phage	  MM1	  served	  as	  controls.	  	  There	  was	  inhibition	  of	  growth	  correlating	  with	  the	  presence	  of	  phage	  MM1,	  but	  no	  effect	  of	  mitomycin	  C	  on	  the	  growth	  of	  strain	  P1121	  carrying	  Spn1	  as	  compared	  to	  the	  isogenic	  Spn1-­‐	  construct	  (Fig.	  2A).	  	  To	  confirm	  that	  the	  mitomycin	  C	  treatment	  was	  activating	  the	  Spn1	  prophage	  under	  these	  conditions,	  phage	  gene	  expression	  was	  assessed.	  	  Gene	  expression	  was	  greatly	  increased	  in	  the	  presence	  of	  mitomycin	  C	  for	  three	  lytic	  genes	  and	  one	  lysogenic	  gene	  across	  Spn1	  	  (Figure	  2B).	  Thus,	  Spn1	  is	  transcriptionally	  activated	  by	  mitomycin	  C,	  but	  not	  able	  to	  lyse	  its	  bacterial	  host.	  	  
Spn1	  causes	  a	  defect	  in	  fitness	  in	  vivo	  	  To	  determine	  the	  effect	  of	  Spn1	  on	  its	  bacterial	  host	  in	  vivo	  we	  used	  a	  murine	  nasopharyngeal	  colonization	  model.	  When	  tested	  individually,	  the	  Spn1+	  and	  Spn1-­‐	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strains	  each	  colonized	  mice	  at	  similar	  densities	  at	  seven	  days	  post-­‐inoculation	  (Figure	  3A).	  	  To	  compare	  their	  relative	  fitness,	  we	  competed	  Spn1+	  and	  Spn1-­‐	  strains	  1:1	  in	  the	  same	  model	  of	  colonization.	  	  At	  seven	  days	  post-­‐inoculation,	  the	  Spn1-­‐	  strain	  significantly	  outcompeted	  the	  Spn1+	  strain	  (competitive	  index	  (CI)	  >70,	  Figure	  3B).	  Competitive	  growth	  in	  vitro	  did	  not	  correlate	  with	  competitive	  effect	  in	  vivo,	  indicating	  that	  Spn1	  confers	  a	  fitness	  disadvantage	  that	  is	  specific	  to	  the	  in	  vivo	  environment	  (Fig.	  3B).	  In	  order	  to	  differentiate	  strains	  post-­‐colonization,	  one	  strain	  was	  marked	  with	  an	  rpsL	  mutation	  conferring	  resistance	  to	  streptomycin.	  	  Data	  shown	  is	  a	  combination	  of	  experiments	  with	  either	  the	  Spn1+	  or	  Spn1-­‐	  strain	  having	  been	  marked	  to	  ensure	  that	  the	  streptomycin	  resistance	  phenotype	  was	  not	  the	  cause	  of	  the	  fitness	  effect	  in	  vitro	  or	  in	  vivo.	  	  	  
A	  trans-­acting	  factor	  from	  Spn1	  affects	  in	  vivo	  fitness	  	  To	  assess	  whether	  the	  effect	  of	  Spn1	  on	  in	  vivo	  fitness	  was	  caused	  by	  cis-­acting	  effects	  on	  the	  flanking	  genes,	  we	  generated	  mutants	  in	  SP_1563	  and	  SP_1564	  in	  strain	  P1121	  and	  tested	  them	  in	  the	  colonization	  model.	  	  The	  loss	  of	  SP_1563	  resulted	  in	  a	  defect	  in	  colonization	  (Fig.	  4A).	  	  To	  determine	  if	  Spn1	  was	  affecting	  transcription	  of	  the	  flanking	  genes,	  we	  compared	  mRNA	  levels	  of	  Spn1+	  and	  Spn1-­‐	  strain	  using	  qRT-­‐PCR.	  Expression	  of	  SP_1563	  and	  SP_1564	  were	  unaffected	  by	  the	  presence	  of	  Spn1.	  	  Therefore,	  an	  effect	  of	  Spn1	  on	  either	  flanking	  gene	  was	  unlikely	  to	  be	  the	  cause	  of	  the	  fitness	  defect	  in	  vivo	  (Figure	  4B).	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  We	  attempted	  to	  reinsert	  the	  Spn1	  prophage	  in	  the	  Spn1-­‐	  strain	  but	  were	  unable	  to	  identify	  transformants	  acquiring	  this	  large	  genetic	  element	  (43kb).	  	  By	  placing	  selectable	  markers	  within	  both	  the	  int	  and	  mml	  genes	  at	  opposite	  poles	  of	  the	  prophage,	  it	  was	  possible	  to	  obtain	  transformants	  of	  the	  Spn1-­‐	  strain	  in	  which	  the	  entire	  locus	  was	  restored.	  	  However,	  interruption	  of	  both	  the	  int	  and	  mml	  genes	  resulted	  in	  a	  strain	  in	  which	  Spn1	  no	  longer	  excised	  spontaneously	  (Fig.	  1C)	  or	  transcribed	  genes	  across	  the	  entire	  prophage	  (Fig.	  4C).	  Theoretically,	  this	  mutant	  should	  maintain	  any	  cis-­‐acting	  effects	  on	  the	  flanking	  genes	  but	  lack	  trans-­‐acting	  effects	  due	  to	  phage	  gene	  expression.	  	  The	  competitive	  index	  of	  the	  Spn1+ΔintΔmml	  strain	  vs.	  the	  Spn1-­‐	  strain	  was	  not	  significantly	  different	  from	  1,	  indicating	  that	  the	  two	  strains	  compete	  equally	  (Fig.	  4D).	  This	  result	  suggests	  a	  trans-­acting	  factor	  requiring	  phage	  gene	  expression	  is	  required	  for	  the	  effect	  of	  Spn1on	  in	  vivo	  fitness.	  	  This	  result	  also	  eliminated	  the	  possibility	  that	  the	  burden	  of	  carrying	  an	  additional	  ~40	  kilobases	  of	  DNA	  was	  responsible	  for	  our	  observations	  on	  fitness	  during	  colonization.	  	  Three	  candidate	  genes	  were	  identified	  as	  potential	  trans-­‐acting	  factors	  in	  the	  fitness	  effect	  of	  Spn1.	  	  First,	  the	  phage	  lysin,	  Mml,	  was	  interrupted	  to	  create	  a	  Spn1+Δmml	  strain.	  The	  competitive	  index	  of	  Spn1-­‐	  vs.	  Spn1+Δmml	  was	  significantly	  greater	  than	  1	  indicating	  that	  the	  Spn1	  mediated	  fitness	  effect	  was	  not	  due	  to	  Mml	  (Figure	  4E).	  	  The	  second	  candidate	  gene	  PblB,	  a	  large	  phage	  tail	  protein,	  was	  removed	  to	  create	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the	  Spn1+ΔpblB	  strain.	  Competition	  between	  Spn1+	  and	  Spn1+ΔpblB	  resulted	  in	  a	  competitive	  index	  not	  significantly	  different	  from	  1	  indicating	  no	  competitive	  advantage	  for	  either	  strain	  (Figure	  4E).	  Lastly,	  the	  integrase	  gene	  (int),	  a	  DNA	  binding	  protein	  that	  mediates	  integration	  of	  the	  phage	  (115),	  was	  interrupted	  to	  create	  Spn1+Δint.	  The	  competitive	  index	  of	  Spn1-­‐	  vs.	  Spn1+Δint	  is	  significantly	  greater	  than	  1	  indicating	  that	  Spn1-­‐	  has	  the	  fitness	  advantage.	  This	  leads	  us	  to	  conclude	  that	  Mml,	  PblB	  or	  integrase	  alone	  does	  not	  confer	  the	  fitness	  defect	  to	  the	  Spn1+	  strain	  in	  vivo.	  	  
The	  presence	  of	  Spn1	  correlates	  with	  resistance	  to	  autolysis	  
	  The	  phage	  lysin,	  Mml	  and	  the	  major	  autolysin	  of	  S.	  pneumoniae,	  LytA,	  are	  homologous	  and	  thought	  to	  be	  functionally	  redundant	  cell	  wall	  amidases	  (57).	  In	  order	  to	  determine	  if	  autolysis	  is	  affected	  by	  the	  presence	  of	  Spn1,	  we	  measured	  bacterial	  growth	  in	  nutrient	  broth	  medium	  over	  a	  period	  of	  24	  hours.	  Autolysis	  was	  delayed	  in	  the	  Spn1+	  strain	  by	  ~5	  hours	  (Figure	  5A).	  	  As	  a	  control,	  lytA	  was	  interrupted	  to	  ensure	  autolysis	  was	  LytA	  dependent	  in	  both	  the	  Spn1+	  and	  Spn1-­‐	  strain.	  No	  autolysis	  was	  observed	  in	  the	  absence	  of	  LytA.	  In	  agreement	  with	  in	  vitro	  competitions	  (Figure	  3B),	  the	  Spn1+	  strain	  outgrew	  the	  Spn1-­‐	  strain,	  however,	  this	  effect	  was	  reversed	  in	  the	  absence	  of	  LytA	  (Figure	  5A).	  	  The	  presence	  or	  absence	  of	  Mml	  had	  no	  effect	  on	  growth	  or	  autolysis	  (data	  not	  shown).	  We	  checked	  levels	  of	  LytA	  expression	  by	  Western	  blot	  and	  detected	  no	  difference	  in	  expression	  of	  LytA	  
	  
69	  
between	  Spn1+	  and	  Spn1-­‐	  strains	  (Figure	  5B).	  	  To	  determine	  if	  Spn1	  affected	  LytA	  activity,	  we	  complemented	  LytA	  activity	  by	  comparing	  growth	  of	  LytA+	  and	  LytA-­‐	  bacteria	  singly	  and	  in	  a	  co-­‐culture.	  If	  active,	  the	  LytA	  secreted	  from	  the	  LytA+	  strain	  should	  be	  able	  to	  lyse	  the	  LytA-­‐	  strain,	  resulting	  in	  a	  growth	  curve	  similar	  to	  that	  of	  a	  LytA+	  strain	  grown	  in	  isolation.	  	  To	  determine	  if	  Spn1	  conferred	  resistance	  to	  LytA,	  we	  measured	  the	  growth	  of	  a	  co-­‐culture	  of	  LytA+	  and	  LytA-­‐	  strains	  in	  both	  Spn1+	  and	  Spn1-­‐	  backgrounds.	  As	  expected,	  the	  growth	  pattern	  mimicked	  that	  of	  a	  LytA+	  strain	  grown	  in	  isolation,	  indicating	  the	  LytA	  is	  active	  and	  able	  to	  lyse	  the	  co-­‐cultured	  strain	  in	  both	  the	  Spn1+	  and	  the	  Spn1-­‐	  backgrounds	  (Figure	  5C).	  	  This	  was	  confirmed	  by	  plating	  bacteria	  and	  colony	  counts	  at	  0,	  5	  and	  8	  hours	  (data	  not	  shown).	  	  To	  test	  if	  LytA’s	  target,	  the	  cell	  wall,	  is	  altered	  in	  the	  Spn1+	  strain,	  we	  co-­‐cultured	  the	  Spn1+	  and	  Spn1-­‐	  strains	  where	  both	  strains	  contained	  LytA.	  	  The	  growth	  curve	  mimicked	  the	  curve	  of	  Spn1+	  strains	  grown	  in	  isolation	  (Figure	  5C).	  	  This	  leads	  us	  to	  conclude	  that	  Spn1	  confers	  resistance	  to	  LytA-­‐mediated	  autolysis.	  	  LytA	  has	  previously	  been	  associated	  with	  virulence(116).	  	  To	  determine	  if	  the	  delay	  in	  autolysis	  was	  the	  cause	  of	  the	  fitness	  defect	  in	  vivo,	  we	  competed	  Spn1+ΔlytA	  and	  Spn1-­‐ΔlytA	  strains	  1:1	  in	  the	  murine	  model	  of	  colonization.	  	  The	  competitive	  advantage	  of	  the	  Spn1-­‐	  strain	  was	  lytA-­independent	  (Figure	  3C).	  Thus,	  the	  altered	  cell	  wall	  physiology	  conferred	  by	  Spn1	  may	  result	  in	  a	  fitness	  defect	  in	  vivo	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independent	  of	  its	  effects	  on	  promoting	  resistance	  to	  LytA-­‐mediated	  autolysis.	  	  	  
Spn1	  affects	  chain	  length	  	  LytA	  is	  also	  involved	  in	  cleavage	  of	  the	  cell	  wall	  to	  allow	  for	  cell	  separation	  during	  division.	  	  Deletion	  of	  lytA	  leads	  to	  the	  formation	  of	  long	  chains	  (130).	  	  Additionally,	  chain	  length	  has	  been	  shown	  to	  have	  an	  important	  role	  during	  both	  colonization	  and	  invasive	  disease	  (38,	  126).	  	  Using	  brightfield	  microscopy	  we	  observed	  that	  the	  mean	  chain	  length	  of	  the	  Spn1-­‐	  strain	  was	  greater	  than	  the	  Spn1+	  strain	  (Fig	  6A&B).	  	  The	  role	  of	  the	  phage	  encoded	  homologue	  Mml	  in	  septation	  and	  chain	  length	  has	  not	  been	  elucidated.	  Surprisingly	  deletion	  of	  lytA	  or	  mml	  did	  not	  lead	  to	  long	  chains	  in	  Spn1+	  bacteria.	  	  However,	  Spn1+ΔlytAΔmml	  bacteria	  did	  form	  long	  chains	  –	  a	  result	  consistent	  with	  the	  functional	  redundancy	  of	  these	  amidases.	  	  Even	  when	  the	  effects	  of	  Mml	  are	  accounted	  for	  by	  comparing	  the	  Spn1-­‐	  strain	  to	  the	  Spn1+Δmml	  strain,	  the	  Spn1-­‐	  strain	  grows	  as	  longer	  chains	  than	  the	  Spn1+	  strain.	  	  The	  observations	  on	  chaining	  provided	  further	  evidence	  that	  the	  presence	  of	  Spn1	  affects	  cell	  wall	  physiology.	  	  	  	  To	  determine	  if	  the	  difference	  in	  chain	  length	  was	  causing	  the	  fitness	  defect	  in	  vivo,	  we	  assessed	  competitive	  colonization	  of	  the	  Spn1-­‐ΔlytA	  strain	  and	  the	  Spn1+ΔlytAΔmml	  strain,	  which	  both	  grow	  as	  long	  chains.	  	  Despite	  controlling	  for	  chain	  length,	  the	  in	  vivo	  fitness	  defect	  of	  the	  Spn1+	  background	  remained	  (Figure	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3C).	  	  	  
Spn1	  affects	  penicillin-­mediated	  lysis	  
	  Penicillin	  acts	  by	  inhibiting	  penicillin-­‐binding	  proteins,	  which	  are	  required	  for	  cross	  linking	  of	  the	  peptidoglycan	  backbone	  to	  prevent	  osmotic	  lysis	  (159).	  Strain	  P1121	  is	  considered	  sensitive	  to	  penicillin	  (minimum	  inhibitory	  concentration	  (MIC)	  50ng/mL).	  However,	  to	  further	  demonstrate	  that	  Spn1	  altered	  the	  pneumococcal	  cell	  wall,	  we	  examined	  whether	  there	  were	  small	  differences	  in	  penicillin	  sensitivity	  conferred	  by	  the	  Spn1	  prophage.	  The	  presence	  of	  Spn1	  resulted	  in	  a	  five-­‐fold	  higher	  MIC	  to	  penicillin.	  This	  effect	  was	  also	  demonstrated	  by	  differences	  in	  growth	  of	  Spn1+	  and	  Spn1-­‐	  strains	  at	  concentrations	  of	  penicillin	  near	  the	  MIC	  (Fig.	  6C).	  	  This	  difference	  in	  growth	  in	  the	  presence	  of	  penicillin	  was	  independent	  of	  LytA	  (Data	  not	  shown).	  	  	  
Discussion	  	  	  	  Our	  findings	  demonstrate	  that	  expression	  of	  the	  phage-­‐like	  genetic	  element	  Spn1	  affects	  cell	  wall	  physiology	  and	  nasopharyngeal	  colonization	  of	  S.	  pneumoniae.	  Several	  aspects	  of	  this	  study	  merit	  further	  comment.	  Excision	  and	  integration	  of	  the	  Spn1	  element	  occurs	  at	  the	  same	  site	  as	  the	  related	  phage	  MM1	  (60).	  Through	  PCR	  analysis	  it	  appears	  that	  a	  circularized	  form	  of	  the	  prophage	  occurs	  during	  normal	  bacterial	  growth,	  although	  we	  were	  unable	  to	  detect	  packaged	  phage	  by	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transmission	  electron	  microscopy	  or	  DNAse	  protection	  assays.	  	  We	  were	  also	  unable	  to	  demonstrate	  phage	  infectivity	  by	  plaque	  assays	  (even	  after	  induction	  by	  mitomycin	  C),	  transduction,	  or	  by	  detection	  of	  lysogenic	  conversion	  after	  co-­‐culture,	  
in	  vitro	  or	  in	  vivo.	  	  We	  were	  also	  unable	  to	  infect	  TIGR4	  or	  R36A	  strains	  with	  Spn1.	  It	  remains	  possible	  that	  under	  different	  growth	  conditions	  or	  in	  its	  natural	  environment,	  Spn1	  forms	  infectious	  phage	  particles.	  Spn1	  could	  have	  become	  defective	  after	  infecting	  this	  strain	  or	  it	  could	  have	  been	  obtained	  through	  transformation	  rather	  than	  infection.	  	  It	  was	  unexpected	  that	  the	  lytic	  genes	  of	  Spn1	  were	  expressed	  during	  normal	  growth	  yet	  we	  did	  not	  detect	  increased	  bacterial	  lysis	  compared	  to	  an	  isogenic	  strain	  lacking	  Spn1.	  	  The	  circularized	  form	  may	  be	  a	  precursor	  to	  Spn1	  gene	  expression	  (and	  allow	  for	  amplification	  of	  gene	  expression),	  since	  mutations	  at	  both	  ends	  of	  the	  element	  in	  Spn1+ΔintΔmml	  prevented	  both	  circularization	  and	  expression	  of	  lytic	  and	  lysogenic	  genes.	  	  The	  inability	  of	  Spn1	  to	  silence	  expression	  of	  lytic	  genes,	  which	  has	  not	  been	  observed	  in	  wild-­‐type	  lambdoid	  phages,	  appears	  to	  have	  required	  adaptation	  by	  the	  host	  bacterium	  (121).	  	  The	  tolerance	  of	  prophage	  gene	  expression,	  even	  when	  further	  induced	  with	  mitomycin	  C,	  suggests	  that	  the	  phage	  lysins,	  which	  usually	  target	  the	  cell	  wall,	  are	  ineffective	  against	  strain	  P1121.	  	  It	  is	  possible	  that	  the	  lysins	  are	  inactive	  or	  only	  a	  small	  portion	  of	  the	  population	  is	  being	  activated	  by	  mitomycin	  C.	  However,	  our	  observations	  suggest	  that	  strain	  P1121	  modifies	  its	  cell	  wall	  so	  that	  it	  is	  less	  susceptible	  to	  lysis.	  	  	  Several	  lines	  of	  evidence	  point	  to	  an	  alteration	  in	  cell	  wall	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physiology	  when	  this	  strain	  carries	  Spn1.	  	  The	  Spn1+	  strain	  has	  a	  delayed	  autolysis	  phenotype,	  not	  due	  to	  any	  alteration	  in	  amounts	  or	  activity	  of	  the	  major	  amidase	  responsible	  for	  autolysis,	  LytA.	  	  This	  suggests	  that	  LytA’s	  target,	  the	  cell	  wall,	  is	  more	  resistant	  to	  its	  enzymatic	  activity.	  	  Moreover,	  the	  Spn1+	  strain	  showed	  an	  increased	  resistance	  to	  penicillin.	  	  We	  did	  not	  detect	  an	  elevated	  amount	  of	  peptidoglycan	  when	  purified	  from	  the	  Spn1+	  strain	  or	  a	  thicker	  cell	  wall	  in	  electron	  micrographs	  of	  the	  Spn1+	  strain	  (data	  not	  shown).	  The	  effect	  of	  penicillin	  suggests	  that	  alteration	  of	  the	  cell	  wall	  could	  be	  due	  to	  increased	  cross-­‐linking,	  since	  this	  is	  the	  step	  inhibited	  by	  the	  drug.	  Increased	  integrity	  through	  more	  extensive	  cross-­‐linking	  within	  the	  cell	  wall	  could	  also	  explain	  the	  increased	  resistance	  to	  LytA	  and	  delayed	  autolysis	  –	  phenotypes	  previously	  linked	  to	  altered	  penicillin	  resistance	  (104,	  113).	  Finally,	  alterations	  in	  cell	  wall	  physiology	  may	  be	  seen	  as	  differences	  in	  cell	  division/separation	  resulting	  in	  abnormal	  chain	  formation.	  The	  presence	  of	  Spn1	  correlated	  with	  decreased	  average	  chain	  length.	  	  	  Studies	  on	  LytA	  have	  shown	  that	  lytA	  mutants	  do	  not	  autolyse	  and	  display	  increased	  chain	  length	  (130).	  	  However,	  in	  this	  study,	  these	  effects	  of	  LytA	  were	  unpaired.	  The	  Spn1+	  strain	  demonstrated	  delayed	  autolysis	  indicating	  resistance	  to	  LytA,	  yet	  shorter	  chains,	  which	  was	  previously	  thought	  to	  be	  associated	  with	  an	  increase	  in	  susceptibility	  to	  LytA.	  	  This	  apparent	  discrepancy	  could	  be	  indicative	  of	  the	  secretion	  and	  localization	  of	  LytA	  on	  the	  bacterial	  cell	  surface.	  	  A	  recent	  study	  on	  Mml	  and	  LytA	  showed	  that	  phosphorylcholine	  is	  required	  for	  secretion	  of	  both	  of	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these	  lysins.	  	  The	  authors	  of	  that	  study	  proposed	  that	  LytA	  binds	  the	  phosphorylcholine	  as	  it	  is	  added	  to	  the	  cell	  wall	  during	  division	  (56).	  	  This	  is	  supported	  by	  another	  study	  demonstrating	  that	  LytA	  is	  localized	  to	  the	  nascent	  peptidoglycan	  (104).	  This	  suggests	  that	  the	  change	  in	  the	  cell	  wall	  that	  leads	  to	  resistance	  to	  LytA	  in	  the	  Spn1+	  strain	  might	  occur	  during	  maturation	  of	  the	  peptidoglycan,	  leaving	  the	  nascent	  peptidoglcyan	  formed	  during	  division	  susceptible	  to	  LytA-­‐mediated	  cleavage,	  resulting	  in	  reduced	  chain	  length.	  	  	  The	  precise	  nature	  of	  the	  alteration	  in	  the	  pneumococcal	  cell	  wall	  required	  for	  tolerance	  of	  Spn1	  is	  the	  subject	  of	  further	  investigation.	  Factors	  regulating	  cell	  wall	  synthesis,	  quantity	  of	  peptidoglycan	  per	  cell	  and	  level	  of	  cross-­‐linking	  are	  incompletely	  understood.	  These	  differences	  could	  be	  the	  direct	  action	  of	  an	  unknown	  protein	  encoded	  on	  the	  prophage.	  However,	  it	  is	  possible	  that	  the	  over-­‐production	  of	  prophage	  products,	  including	  the	  lysin	  and	  holins,	  leads	  to	  a	  general	  stress	  response	  in	  the	  host	  bacterium.	  	  Stress	  responses	  in	  bacteria	  often	  induce	  changes	  in	  the	  cell	  wall.	  For	  example	  in	  Staphylococcus	  aureus	  there	  is	  evidence	  of	  cell	  wall	  thickening	  in	  the	  presence	  of	  vancomycin	  (34).	  Also	  the	  CiaRH	  two-­‐component	  system	  in	  S.	  pneumoniae	  is	  thought	  to	  maintain	  cell	  wall	  integrity	  in	  the	  presence	  of	  various	  stressors	  (97).	  	  	  The	  presence	  of	  Spn1	  was	  associated	  with	  reduced	  fitness	  during	  competitive	  colonization	  –	  an	  effect	  that	  may	  be	  related	  to	  the	  changes	  in	  its	  cell	  wall.	  	  There	  are	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several	  phenotypes	  associated	  with	  the	  presence	  of	  Spn1	  that	  may	  affect	  fitness	  during	  colonization.	  Most	  notably	  chain	  length	  increases	  adherence	  to	  epithelial	  cells	  (126),	  and	  the	  presence	  and	  action	  of	  LytA	  is	  important	  during	  pathogenesis,	  although	  the	  exact	  mechanism	  is	  unclear	  (116).	  	  However,	  when	  we	  eliminate	  differences	  in	  chain	  length	  and	  the	  effects	  of	  LytA,	  but	  maintain	  the	  presence	  of	  Spn1,	  we	  still	  observe	  a	  fitness	  defect	  in	  the	  Spn1+	  strain	  during	  competitive	  colonization.	  This	  implies	  that	  the	  inherent	  differences	  in	  the	  cell	  wall,	  not	  these	  subsequent	  phenotypes,	  are	  responsible	  for	  the	  fitness	  defect	  in	  vivo.	  Theoretically,	  alteration	  of	  the	  cell	  wall	  in	  response	  to	  the	  prophage	  could	  be	  a	  metabolic	  burden	  on	  the	  Spn1+	  strain,	  which	  gives	  the	  Spn1-­‐	  strain	  the	  edge	  in	  competitive	  colonization.	  The	  in	  vitro	  competition	  data	  supports	  this	  concept	  since	  the	  competitive	  effect	  is	  lost	  in	  a	  nutrient	  rich	  environment.	  Additionally,	  the	  cell	  wall	  anchors	  many	  factors	  linked	  to	  fitness	  for	  colonization,	  which	  could	  also	  be	  playing	  a	  role	  (81).	  	  	  The	  competitive	  fitness	  defect	  and	  alteration	  of	  the	  cell	  wall	  are	  both	  dependent	  on	  prophage	  gene	  expression.	  This	  indicates	  that	  a	  trans-­‐acting	  factor	  encoded	  on	  the	  prophage	  could	  be	  responsible	  for	  these	  phenotypes.	  We	  eliminated	  the	  potential	  contribution	  of	  three	  candidate	  trans-­‐acting	  factors,	  Mml,	  PblB	  and	  Integrase.	  	  Mml	  has	  previously	  been	  shown	  to	  be	  redundant	  with	  LytA	  in	  phage	  progeny	  release	  indicating	  it	  contributes	  to	  bacterial	  lysis	  (57).	  	  Integrase	  is	  a	  DNA	  binding	  protein	  involved	  in	  the	  excision	  and	  integration	  of	  the	  prophage	  (115).	  	  PblB	  was	  originally	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annotated	  on	  phages	  of	  Streptococcus	  mitis	  and	  is	  thought	  to	  mediate	  adherence	  to	  platelets	  (14).	  We	  saw	  no	  differences	  in	  adherence	  of	  the	  Spn1+	  and	  Spn1-­‐	  bacteria	  to	  A549	  human	  epithelial	  cells	  in	  culture	  (data	  not	  shown).	  While	  we	  eliminated	  several	  potential	  trans-­‐acting	  factors,	  there	  are	  ~63	  open	  reading	  frames	  annotated	  on	  Spn1,	  many	  of	  which	  have	  an	  unknown	  function	  and	  could	  be	  affecting	  bacterial	  fitness.	  The	  increased	  protein-­‐synthesis	  burden	  of	  carrying	  Spn1	  could	  also	  account	  for	  the	  effect	  on	  fitness	  in	  vivo.	  	  	  The	  question	  remains	  as	  to	  why	  the	  bacterium	  does	  not	  spontaneously	  cure	  Spn1	  if	  it	  is	  associated	  with	  a	  fitness	  cost.	  	  S.	  pneumoniae	  is	  highly	  proficient	  at	  recombination	  and	  it	  should	  readily	  eliminate	  any	  disadvantageous	  genetic	  elements,	  yet	  Spn1	  remains	  stably	  integrated	  (71).	  Moreover,	  in	  a	  study	  of	  human	  experimental	  pneumococcal	  colonization,	  Spn1	  was	  present	  in	  the	  initial	  clinical	  isolate	  used	  to	  inoculate	  several	  volunteers,	  and	  also	  in	  all	  the	  isolates	  retrieved	  from	  participants	  up	  to	  122	  days	  later	  (101)(data	  not	  shown).	  Although	  this	  lineage	  was	  successful	  at	  colonization	  in	  this	  study,	  it	  may	  not	  be	  adept	  at	  competing	  with	  other	  pneumococci.	  Colonization	  by	  multiple	  strains	  of	  pneumococci	  commonly	  occurs	  in	  children	  (25).	  Prophages	  are	  known	  to	  protect	  against	  super-­‐infection	  by	  other	  related	  phages.	  	  It	  is	  possible	  that	  selective	  pressure	  from	  other	  phages	  during	  natural	  colonization	  is	  sufficient	  to	  maintain	  this	  element.	  	  	  In	  conclusion,	  we	  have	  determined	  that	  a	  novel	  prophage,	  Spn1,	  is	  associated	  with	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altering	  the	  bacterial	  cell	  wall	  and	  a	  fitness	  defect	  during	  competitive	  colonization.	  This	  type	  of	  interaction	  between	  a	  prophage	  and	  its	  bacterial	  host,	  where	  the	  bacteria	  tolerate	  the	  phage	  despite	  its	  negative	  effects,	  has,	  to	  our	  knowledge,	  not	  been	  described	  previously.	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Figure	  1.	  Genetic	  map	  and	  activity	  of	  Spn1	  A.	  The	  strain	  P1121,	  including	  the	  genetic	  element	  Spn1,	  was	  sequenced	  on	  an	  Illumina	  Hi-­‐Seq	  and	  annotated	  using	  RAST.	  Sixty-­‐three	  open	  reading	  frames	  were	  identified	  and	  are	  indicated	  as	  block	  arrows	  showing	  the	  direction	  of	  transcription.	  	  Genes	  were	  arranged	  in	  lytic	  or	  lysogenic	  clusters	  by	  putative	  function	  in;	  lysis	  (black),	  structural	  genes	  (dark	  gray),	  replication	  genes	  (white)	  and	  lysogeny	  (light	  gray).	  B.	  Schematic	  of	  Spn1	  (circle)	  integration	  between	  genes	  SP_1563	  and	  SP_1564	  (dashed	  arrows	  show	  direction	  of	  transcription).	  The	  attachment	  site,	  15bp	  at	  the	  3’	  end	  of	  the	  coding	  region	  of	  
SP_1564	  is	  indicated	  by	  a	  black	  bar.	  The	  light	  gray	  bar	  indicates	  a	  noncoding	  intergenic	  region.	  Small	  arrows	  represent	  the	  location	  of	  primers.	  C.	  PCR	  products	  showing	  the	  presence	  of	  a	  circularized	  element	  (primers	  a	  and	  b),	  integration	  at	  the	  attachment	  site	  (primers	  a	  and	  d),	  or	  the	  attachment	  site	  lacking	  Spn1(primers	  c	  and	  d)	  in	  the	  indicated	  strains.	  	  Size	  markers	  are	  indicated	  in	  base	  pairs.	  D.	  Levels	  of	  mRNA	  relative	  to	  the	  housekeeping	  gene	  gyrA	  as	  determined	  by	  qRT-­‐PCR	  for	  genes	  across	  Spn1.	  The	  position	  of	  specific	  genes	  is	  designated	  in	  A	  and	  shaded	  to	  match	  the	  functional	  cluster	  in	  the	  genetic	  map.	  Data	  are	  shown	  as	  Mean	  ±SEM,	  *P<0.05,	  ns,	  non-­‐significant	  by	  Student	  t-­‐test.	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  Figure	  2.	  Activation	  of	  Spn1	  by	  mitomycin	  C.	  A.	  Growth	  of	  strain	  P1121	  with	  or	  without	  Spn1	  and	  strain	  TIGR4	  with	  and	  without	  MM1	  in	  C+Y	  medium.	  	  Mitomycin	  C	  (5μg/mL)	  was	  added	  at	  time	  0.	  	  B.	  Relative	  transcript	  abundances	  as	  determined	  by	  qRT-­‐PCR	  for	  the	  Spn1	  gene	  indicated	  relative	  to	  internal	  control	  gyrA	  is	  shown	  relative	  to	  no	  mitomycin	  C	  treatment.	  Data	  are	  shown	  as	  Mean	  ±SEM.	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  Figure	  3.	  Spn1	  in	  colonization.	  A.	  Density	  of	  Spn1+	  and	  Spn1-­‐	  in	  nasal	  lavages	  obtained	  7	  days	  after	  inoculation.	  Dashed	  line	  indicates	  limit	  of	  detection.	  Comparisons	  between	  strains	  were	  made	  using	  the	  Mann	  Whitney	  test.	  B.	  Competitive	  indexes	  (CI=output	  ratio/input	  ratio)	  of	  Spn1-­‐/Spn1+	  following	  growth	  for	  5	  hrs	  in	  C+Y	  medium	  (in	  vitro)	  or	  7	  days	  of	  colonization	  (in	  vivo).	  C.	  Competitive	  indexes	  for	  Spn1-­‐ΔlytA/Spn1+ΔlytA	  and	  Spn1-­‐ΔlytA/Spn1+ΔlytAΔMml	  to	  determine	  the	  competitive	  advantage	  without	  autolysis	  and	  with	  equivalent	  chain	  length,	  respectively.	  Each	  symbol	  is	  from	  a	  single	  mouse	  or	  culture.	  CI	  is	  based	  on	  patching	  
≥50	  colonies	  on	  selective	  medium	  to	  distinguish	  strains.	  One	  sample	  t-­‐test	  was	  used	  to	  determine	  if	  CIs	  were	  significantly	  different	  from	  a	  hypothetical	  value	  of	  1,	  which	  would	  indicate	  no	  competitive	  advantage	  or	  disadvantage.	  *P<0.05,	  ***P<0.001.	  ns,	  non-­‐significant.	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Figure	  5.	  	  Spn1	  has	  an	  effect	  on	  LytA-­‐mediated	  autolysis.	  A.	  Growth	  and	  autolysis	  of	  strain	  P1121	  (Spn1+)	  and	  designated	  mutants	  in	  C+Y	  broth	  medium	  over	  24	  hours	  at	  37°C.	  Data	  are	  shown	  as	  Mean	  ±SEM.	  B.	  Protein	  levels	  of	  LytA	  as	  determined	  by	  Western	  blot	  on	  whole	  cell	  lysates	  of	  Spn1+,	  Spn1-­‐	  and	  Spn1+ΔlytA	  strains	  with	  anti-­‐LytA	  antibody.	  Pneumolysin	  was	  used	  as	  a	  loading	  control.	  C.	  Growth	  and	  autolysis	  of	  strain	  P1121	  and	  designated	  mutants	  with	  and	  without	  LytA	  or	  Spn1	  complemented	  by	  co-­‐culture	  in	  BHI	  for	  16	  hours	  at	  37°C.	  For	  each	  graph	  shown,	  red	  and	  green	  lines	  are	  strains	  grown	  in	  isolation.	  	  Blue	  line	  is	  the	  co-­‐culture	  of	  those	  two	  strains.	  Data	  are	  shown	  as	  Mean	  ±SEM.	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Figure	  6.	  Spn1	  has	  an	  effect	  on	  the	  cell	  wall.	  A.	  Images	  taken	  of	  strain	  P1121	  and	  mutant	  indicated	  in	  mid-­‐log	  phase	  culture	  using	  a	  brightfield	  microscope.	  B.	  Average	  pixels	  per	  particle	  as	  determined	  by	  ImageJ	  analysis	  to	  quantify	  chain	  length.	  Student	  T	  test	  was	  used	  to	  compare	  groups.	  ***P<0.001.	  ns,	  non-­‐significant.	  Data	  are	  shown	  as	  Mean	  ±SEM.	  C.	  Growth	  of	  Spn1+	  and	  Spn1-­‐	  strains	  in	  30ng/mL	  of	  penicillin	  in	  TS	  over	  5	  hours	  at	  37°C.	  Data	  are	  shown	  as	  Mean	  ±SEM.	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Table	  1.	  Bacterial	  Strains	  
Strain 
No. Designation Background Descriptiona Source 
P1121 Spn1+   Human challenge study isolate  (101) 
P1397 Spn1+ Smr P1121 Smr spontaneous mutation This study 
P2197 MM1- TIGR4    (92) 
P2198 MM1+ TIGR4    (92) 
P2282 Spn1+ΔlytA P1121 lytA::Spr This study 
P2308 Spn1+Δmml P1121 mml::Kmr This study 
P2345 Spn1+ΔSP_1563 P1121 sp_1563::Spr This study 
P2348 Spn1+ΔSP_1564 P1121 sp_1564::Emr This study 
P2352 Spn1- Smr P1397 
unmarked in-frame Spn1 
deletion, Smr  This study 
P2373 Spn1+ΔpblB P1121 pblB::Emr This study 
P2379 Spn1-ΔlytA P2385 lytA::Spr transformed with P2282 This study 
P2380 Spn1+ΔmmlΔlytA P2308 
mml::Kmr lytA:Spr transformed 
with P2282 This study 
P2385 Spn1- P2352 
transformed with P1121 to 
remove Smr This study 
P2386 Spn1+ΔintΔmml P2385 
mml:: Kmr int::Emr transformed 
with P2387 This study 
P2387 Spn1+ΔintΔmml P2308 
mml::Kmr int::Emr transformed 
with 2388 This study 
P2388 Spn1+Δint P1121 int::Emr This study 




Table	  2.	  Primers	  for	  mutant	  construction	  and	  qRT-­‐PCR	  
Primer Gene Direction Sequence Source 
AttF SP_1563 Forward TGTGGGTGGTGGTCCTGTCG This study 
AttR SP_1564 Reverse ATGCCAAACTGGCCCGTCAC This study 
EGP4 int Forward GAAGATAGGAGGATAAACTGG (60) 
EGP9 mml Reverse AACTGCAGAAATTGTTCTTTCACCGCAGG (60) 
Spn1-2 mml Reverse CATTATCCATTAAAAATCAAACAACTGCAGAAATTGTTCTTT
CACCGCAGG 
This study 
Spn1-3 Janus Forward CCTGCGGTGAAAGAACAATTTCTGCAGTTGTTTGATTTTTA
ATGGATAATG 
This study 
Spn1-4 Janus Reverse CCAGTTTATCCTCCTATCTTCCTTTCCTTATGCTTTTGGAC This study 
Spn1-5 int Forward GTCCAAAAGCATAAGGAAAGGAAGATAGGAGGATAAACTG
G 
This study 
1563-1 SP_1561 Forward TATAGCCGCCCGGTGTCTGG This study 
1563-2 SP_1563 Reverse CACTTTATTAATTTGTTCGTATGTATTCAGTTTCTCCTTTGT
TTTTTCTAGTCAGTTTAT 
This study 
1563-3 SpecR Forward ATAAACTGACTAGAAAAAACAAAGGAGAAACTGAATACATA
CGAACAAATTAATAAAGTG 
This study 
1563-4 SpecR Reverse CGAATCCTATGTGACTCGTGGTTCTTTTTTCCCGAGCTCG
AATTGACGCGGATCC 
This study 
1563-5 SP_1563 Forward GGATCCGCGTCAATTCGAGCTCGGGAAAAAAGAACCACG
AGTCACATAGGATTCG 
This study 
1563-6 mml Reverse CGCTGCAACAGGCTGGCAGA This study 
1564-1 int Forward TGGAGAAGAAAACTCCCCAGGCA This study 
1564-2 SP_1564 Reverse GGTGCAAGTCAGCACGAACGATATAAAGCAACCCCTTGAA
TTATCAA 
This study 
1564-3 ermR Forward ATAATTCAAGGGGTTGCTTTATATCGTTCGTGCTGACTTGC
ACC 
This study 
1564-4 ermR Reverse GATGCGCATTATACAGGTGAAAAATGAGTAACGTGTAACT
TTCCAAAT 
This study 
1564-5 SP_1564 Forward ATTTGGAAAGTTACACGTTACTCATTTTTTCACCTGTATAAT
GCGCATC 
This study 
1564-6 SP_1565 Reverse GGCCAGCCGTCGAGTAGTGC This study 
mml-1 SP_1563 Forward GCAGCCTTTTATGCCCACCTACGCC This study 
mml-2 mml Reverse CTCTGGAATAGGCATAGACACTATCCACCGCAGGCTCAG
GCTTGCGG 
This study 
mml-3 kanR Forward CCGCAAGCCTGAGCCCTGCGGTGGATAGTGTCTATGCCT
ATTCCAGAG 
This study 
mml-4 kanR Reverse GACGCATGGAAAGGACGATAGGGACACGTTTTTGTGGTG
AGAAAC 
This study 
mml-5 mml Forward GTTTCTTCACCACAAAAACGTGTCCCTATCGTCCTTTCCAT
GCGTC 
This study 
mml-6 pblB Reverse CTGAGCATAAGGAATAGGAGGTGTG This study 
int-1 int Forward ATGTGGATGGAAGAACTTTCCAAC This study 
int-2 int Reverse GGTGCAAGTCAGCACGAAACAAGTGCTTTTATTTCTTGCA
TGGT 
This study 
int-3 ermR Forward ACCATGCAAGAAATAAAAGCACTTGTTTCGTGCTGACTTG
CACC 
This study 
int-4 ermR Reverse GTACTTTTGGTGATATTCTCGACGATTAAGAGTAACGTGTA
ACTTTCCAAAT 
This study 
int-5 int Forward ATTTGGAAAGTTACACGTTACTCTTAATCGTCGAGAATATC
ACCAAAAGTAC 
This study 
int-6 int Reverse AGTATCTAATTTATTGACCAGTTTCTCCTCC This study 
PblB-1 ORF61 Forward GAAGCTGGTAAAGAGGCGGT This study 
PblB-2 pblB Reverse ATGGTGCAAGTCAGCACGAATCCTTGGCAAACATGGCTCT This study 
PblB-3 ermR Forward AGAGCCATGTTTGCCAAGGATTCGTGCTGACTTGCACCAT This study 
PblB-4 ermR Reverse ATGGTTTCAGCCTCTTGAGCTAGTAACGTGTAACTTTCCAA This study 
PblB-5 pblB Forward TTGGAAAGTTACACGTTACTAGCTCAAGAGGCTGAAACCA
T 
This study 
PblB-6 ORF55 Reverse GTCAGGATTGCCCTCTGCAT This study 
LytA-1 dinF Forward TTGGCTAGTTCGACAGATGGTTAC This study 





LytA-3 specR Forward TGAGTTGTTTTAATTGATAAGGAGTAGAAGAATACATACGA
ACAAATTAATAAAGTG 
This study 
LytA-4 specR Reverse ATGCGCTGTTCTGATTTGAAAGACATTCCCCCGAGCTCGA
ATTGACGCGGATCC 
This study 
LytA-5 lytA Forward GGATCCGCGTCAATTCGAGCTCGGGGGAATGTCTTTCAAA
TCAGAACAGCGCAT 
This study 
LytA-6 SP_1935 Reverse TGAGTTCTATTGGCATTTTCTCTG This study 
RTmmlF mml Forward CCACTCAACAGGCAACCGTA This study 
RTmmlR mml Reverse CTTCCGTTGTTCACAGGACC This study 
RTholinF holin Forward TTGCGTAAAGGCGGAGAGAA This study 
RTholinR holin Reverse AGCTACTTGCTCAACGGCAT This study 
RTPblBF pblB Forward TATCAAGGCCGAATCGGTGG This study 
RTPblBR pblB Reverse GGCACCATTCCCCATACCAA This study 
RTORF4
2F 
ORF42 Forward GGACGCAGACTACAGCAAGT This study 
RTORF4
2R 
ORF42 Reverse CATATCGGCAGGCACGTACT This study 
RTORF2
0F 
ORF20 Forward AAGAGTCAAATCGGTGGCGT This study 
RTORF2
0R 
ORF20 Reverse GCTCCTTTGTCAGCAATCGAC This study 
RTC1Re
pF 
C1Rep Forward TCGCACAGATAATCCTACCATCGCT This study 
RTC1Re
pR 
C1Rep Reverse TGAAGCGCATAGCAGTAGAGGCA This study 
RTintF int Forward CGACTTAGCGAACGTTTCCAGCCA This study 
RTintR int Reverse ACGTGGGGGTCGTGGTGTCC This study 
RT1563F SP_1563 Forward CGACCTCAACCGTCACAAGA This study 
RT1563R SP_1563 Reverse TAGCAGCAGTCACCGATAGC This study 
RT1564F SP_1564 Forward AGGTCGTTACGGGTTTCTCG This study 
RT1564R SP_1564 Reverse ACCTATCTCCAGCGAGCAGA This study 
RTgyrAF gyrA Forward GCCCTTTGGCAGTCCGACCA This study 
RTgyrAR gyrA Reverse ACGTGGGGGTCGTGGTGTCC This study 	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Chapter	  4	  	  






Spn1	  gene	  expression	  




Spn1	  infectivity	  	  Though	  we	  were	  able	  to	  detect	  phage	  excision	  and	  gene	  expression,	  we	  could	  not	  detect	  phage	  particles	  or	  infectivity	  despite	  extensive	  attempts	  to	  do	  so.	  Four	  techniques	  were	  attempted,	  plaque	  assays,	  selection	  after	  lysogenic	  conversion,	  DNase	  protection	  assays	  and	  electron	  microscopy.	  	  Plaque	  assays	  using	  Streptococcus	  pneumoniae	  are	  known	  to	  be	  difficult	  and	  successful	  plaque	  assays	  are	  usually	  performed	  under	  non-­‐physiologic	  condition.	  	  For	  example	  phages	  will	  not	  infect	  encapsulated	  pneumococci	  in	  a	  laboratory	  setting	  (17).	  Typically	  the	  only	  indicator	  strain	  used	  for	  plaque	  assays	  is	  R36A	  an	  unencapsulated	  lab	  strain.	  The	  correct	  growth	  conditions	  for	  top	  agar	  is	  also	  difficult	  due	  to	  S.	  pneumoniae’s	  oxygen	  requirements	  and	  hydrogen	  peroxide	  production.	  	  Typically	  S.	  pneumoniae	  will	  only	  form	  micro-­‐colonies	  within	  the	  top	  agar	  instead	  of	  the	  lawn	  needed	  for	  the	  spread	  of	  phage	  infection	  to	  create	  a	  plaque.	  Lastly	  the	  phages	  themselves	  seem	  to	  be	  very	  unstable,	  lasting	  only	  about	  24	  hours	  after	  being	  harvested.	  Clearly	  the	  high	  incidence	  of	  prophages	  amongst	  pneumococcal	  isolates	  indicates	  that	  phages	  are	  successfully	  infecting	  the	  bacteria	  in	  their	  natural	  environment.	  	  To	  more	  closely	  mimic	  the	  infection	  that	  might	  occur	  in	  nature,	  and	  in	  order	  to	  be	  able	  to	  detect	  low	  infection	  rates,	  we	  looked	  for	  lysogenic	  conversion	  of	  the	  Spn1-­‐	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strain	  using	  a	  phage	  marked	  with	  a	  kanamycin	  resistance	  cassette	  in	  the	  gene	  mml.	  It	  had	  previously	  been	  shown	  that	  Mml	  and	  LytA	  were	  redundant	  during	  lysis	  after	  phage	  infection	  so	  replacing	  this	  gene	  should	  have	  no	  effect	  on	  Spn1’s	  ability	  to	  infect	  other	  bacteria	  (57).	  We	  used	  the	  streptomycin	  resistance	  marker	  to	  differentiate	  the	  originally	  Spn1+	  and	  Spn1-­‐	  strains.	  After	  co-­‐colonizing	  mice	  with	  Spn1+Δmml(kanr)	  and	  Spn1-­‐(strr),	  lavages	  were	  plated	  using	  a	  double	  selection,	  TS	  with	  kanamycin	  and	  streptomycin.	  	  No	  colonies	  grew	  indicating	  that	  no	  Spn1-­‐	  bacteria	  had	  acquired	  the	  phage	  during	  co-­‐colonization.	  We	  repeated	  this	  experiment	  after	  co-­‐culture	  in	  several	  types	  of	  media	  and	  buffers	  and	  also	  using	  antibiotic	  markers	  in	  different	  phage	  genes	  but	  never	  detected	  lysogenic	  conversion	  of	  the	  Spn1-­‐	  strain.	  	  It	  is	  possible	  that	  Spn1	  is	  not	  infectious	  but	  can	  still	  make	  phage	  particles.	  In	  electron	  micrographs	  of	  P1121	  from	  uninduced	  cultures,	  we	  did	  not	  see	  phage	  particles	  (Figure	  1A).	  	  However,	  with	  unknown	  phage	  morphology,	  it	  might	  be	  difficult	  to	  discern	  a	  phage	  particle	  from	  other	  extracellular	  structures.	  Currently	  no	  antibodies	  against	  any	  Spn1	  encoded	  protein	  have	  been	  made	  making	  further	  identification	  using	  immunogold	  labeling	  impossible.	  To	  further	  determine	  the	  presence	  of	  phage	  capsids	  we	  used	  a	  DNase	  protection	  assay.	  In	  this	  assay	  we	  induced	  potential	  phage	  particles	  using	  mitomycin	  C.	  	  We	  then	  treated	  with	  DNase.	  	  If	  phage	  capsids	  are	  present	  they	  will	  protect	  phage	  DNA	  from	  the	  DNase	  but	  not	  bacterial	  DNA.	  After	  DNase	  treatment	  we	  quantified	  phage	  DNA	  using	  qPCR	  but	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could	  not	  reliably	  detect	  protection	  of	  phage	  DNA	  from	  DNase.	  	  Often	  times	  phage	  capsids	  are	  not	  stable.	  There	  is	  the	  possibility	  that	  variations	  in	  the	  conditions	  of	  both	  EM	  experiments	  and	  the	  DNase	  protection	  assays	  altered	  stability	  of	  the	  capsid	  making	  it	  difficult	  for	  us	  to	  detect.	  	  
Spn1	  stability	  	  Bacteria	  are	  rapidly	  evolving	  organisms	  and	  S.	  pneumoniae	  is	  particularly	  adept	  at	  DNA	  recombination.	  	  Therefore	  it	  seems	  unlikely	  that	  the	  pneumococcus	  would	  retain	  a	  genetic	  element	  that	  confers	  a	  fitness	  defect.	  	  Yet	  phage	  Spn1	  is	  highly	  stable,	  remaining	  integrated	  in	  the	  bacterial	  genome	  throughout	  an	  experimental	  human	  colonization	  period	  of	  122	  days	  (101).	  A	  simple	  explanation	  for	  this	  is	  that	  Spn1	  provides	  a	  fitness	  advantage	  in	  some	  setting	  other	  than	  colonization	  of	  a	  murine	  nasopharynx.	  	  	  It	  is	  possible	  that	  Spn1	  provides	  a	  fitness	  advantage	  during	  invasive	  disease.	  	  The	  environment	  in	  the	  bloodstream	  or	  in	  sterile	  sites	  such	  as	  the	  lung	  or	  middle	  ear	  have	  different	  selective	  pressures	  and	  require	  a	  separate	  set	  of	  pneumococcal	  genes	  for	  survival.	  	  We	  were	  unable	  to	  test	  the	  effect	  of	  Spn1	  on	  the	  fitness	  of	  P1121	  in	  these	  environments	  because	  this	  strain	  of	  bacteria	  is	  avirulent	  in	  the	  mouse	  model.	  	  However,	  it	  is	  unlikely	  that	  this	  is	  the	  reason	  for	  Spn1’s	  stable	  presence.	  	  Disease	  states	  are	  an	  evolutionary	  dead	  end	  for	  the	  bacteria	  with	  no	  transmission	  occurring	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from	  any	  of	  its	  disease	  sites.	  Therefore,	  any	  factor	  that	  improves	  bacterial	  fitness	  only	  in	  a	  disease	  state	  is	  unlikely	  to	  be	  maintained.	  	  A	  key	  selective	  pressure	  in	  all	  bacterial	  pathogens	  is	  the	  ability	  to	  be	  transmitted	  from	  one	  host	  to	  another.	  The	  pneumococcus	  is	  likely	  transmitted	  from	  its	  carrier	  state.	  Co-­‐housed	  adult	  mice	  do	  no	  transmit	  the	  pneumococcus.	  However	  a	  transmission	  model	  was	  developed	  using	  infant	  mice	  co-­‐infected	  with	  influenza	  virus	  (49).	  This	  model	  is	  very	  dependent	  on	  litter	  size	  and	  therefore	  highly	  variable.	  	  Recent	  work	  in	  the	  lab	  also	  shows	  a	  possible	  bottleneck,	  making	  competitive	  experiments	  difficult	  to	  analyze.	  Therefore	  this	  model	  would	  not	  be	  useful	  in	  testing	  the	  effects	  of	  Spn1	  on	  transmission.	  Another	  aspect	  of	  transmission	  is	  survival	  on	  fomites	  such	  as	  plastic	  or	  other	  surfaces.	  The	  pneumococcus	  can	  survive	  desiccation	  and	  persist	  for	  up	  to	  three	  weeks	  on	  plastic	  petri	  dishes	  (156).	  We	  repeated	  these	  experiments	  and	  did	  not	  see	  improved	  survival	  in	  the	  Spn1+	  strain	  (data	  not	  shown).	  However,	  it	  remains	  possible	  that	  Spn1	  improves	  transmission	  in	  some	  other	  way.	  	  Another	  possibility	  is	  that	  the	  phage	  has	  evolved	  mechanisms	  to	  maintain	  itself.	  In	  several	  species	  of	  bacteria,	  abortive	  infection	  systems	  (ABi)	  have	  been	  characterized	  as	  a	  phage	  resistance	  mechanism.	  	  These	  systems	  detect	  phage	  infection	  and	  induce	  an	  apoptosis	  like	  pathway,	  which	  limits	  the	  spread	  of	  phage	  infection	  (22).	  Subsequently,	  phages	  have	  evolved	  to	  encode	  ABi	  resistance	  proteins.	  To	  our	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knowledge,	  no	  ABi	  system	  has	  been	  identified	  in	  the	  pneumococcus.	  However,	  Spn1	  encodes	  a	  putative	  abortive	  infection	  bacteriophage	  resistance	  protein	  in	  its	  lysogeny	  module.	  Theoretically	  this	  factor	  could	  be	  preventing	  the	  bacteria	  from	  detecting	  phage	  infection	  and	  inducing	  apoptosis-­‐like	  pathway.	  	  However,	  it	  is	  unlikely	  that	  this	  highly	  adaptive	  species	  could	  not	  evolve	  to	  counter	  resist	  this	  mechanism.	  	  The	  most	  likely	  reason	  for	  the	  stability	  of	  Spn1	  is	  a	  difference	  between	  the	  natural	  human	  host	  and	  the	  murine	  model.	  There	  are	  certain	  host	  defenses	  that	  differ	  between	  human	  and	  murine	  immune	  systems.	  Also	  the	  microbiota	  of	  the	  human	  nasopharynx	  is	  very	  different	  from	  that	  of	  a	  mouse.	  	  As	  the	  natural	  host,	  a	  human	  nasopharynx	  is	  more	  likely	  to	  carry	  other	  strains	  of	  pneumococci	  and	  pneumococcal	  phages.	  One	  possibility	  is	  that	  P1121	  can	  use	  Spn1	  in	  bacterial	  competition	  similar	  to	  the	  mechanism	  described	  in	  E.	  faecalis	  where	  phages	  released	  from	  a	  lysogen	  infect	  and	  kill	  competing	  strains	  of	  the	  same	  species	  (52).	  Another	  likely	  possibility	  is	  that	  Spn1	  protects	  the	  bacteria	  from	  super-­‐infection	  by	  other	  phages.	  	  The	  C1repressors	  of	  a	  prophage	  can	  bind	  to	  invading	  phages	  of	  the	  same	  family	  to	  prevent	  superinfection.	  	  The	  pressures	  from	  phage	  in	  a	  human	  nasopharynx	  might	  be	  enough	  to	  maintain	  the	  presence	  of	  Spn1	  despite	  its	  associated	  fitness	  defect.	  We	  were	  unable	  to	  test	  this	  hypothesis	  without	  a	  working	  assay	  to	  detect	  phage	  infection.	  Lastly	  the	  human	  host	  from	  which	  strain	  P1121	  or	  its	  precursor	  was	  isolated	  from	  could	  have	  been	  exposed	  to	  penicillin.	  Perhaps	  the	  small	  difference	  in	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resistance	  to	  penicillin-­‐mediated	  lysis	  is	  enough	  to	  maintain	  the	  presence	  of	  Spn1.	  	  
Cell	  wall	  in	  vivo	  	  We	  have	  shown	  that	  the	  change	  in	  the	  cell	  wall	  associated	  with	  Spn1	  might	  be	  the	  cause	  of	  the	  fitness	  defect	  in	  vivo.	  	  There	  are	  several	  potential	  mechanisms	  behind	  this	  effect.	  The	  change	  in	  the	  cell	  wall	  might	  affect	  metabolic	  burden	  or	  affect	  the	  many	  cell	  wall	  bound	  virulence	  factors	  such	  as	  choline	  binding	  proteins,	  c-­‐polysaccharide	  and	  capsule.	  	  The	  simplest	  explanation	  for	  a	  physiological	  change	  in	  the	  cell	  wall	  affecting	  bacterial	  fitness	  in	  vivo	  is	  a	  change	  in	  metabolic	  burden.	  This	  mechanism	  seems	  likely	  due	  to	  the	  finding	  that	  the	  fitness	  defect	  is	  ameliorated	  during	  growth	  in	  nutrient	  rich	  broth.	  Experiments	  in	  minimal	  media	  to	  test	  this	  possibility	  were	  grossly	  affected	  by	  the	  streptomycin	  resistance	  marker	  and	  therefore	  did	  not	  provide	  useful	  data.	  Metabolic	  burden	  would	  theoretically	  also	  be	  affected	  by	  the	  burden	  of	  translating	  phage	  proteins.	  We	  found	  that	  the	  Spn1+	  strain	  had	  a	  higher	  protein	  content,	  specific	  to	  the	  supernatant,	  which	  could	  indicate	  the	  burden	  of	  phage	  proteins	  (Figure	  2A).	  However,	  the	  relative	  protein	  content	  did	  not	  change	  in	  the	  presence	  of	  mitomycin	  C,	  which	  correlated	  with	  the	  increased	  gene	  expression	  (Figure	  2B	  and	  Chapter	  3	  Figure	  2B).	  It	  is	  therefore	  likely	  that	  both	  the	  metabolic	  burden	  of	  both	  phage	  protein	  synthesis	  and	  the	  compensatory	  change	  in	  the	  cell	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wall	  are	  playing	  a	  role	  in	  vivo.	  	  However,	  there	  are	  multiple	  other	  potential	  effects	  that	  a	  change	  in	  the	  cell	  wall	  could	  have	  on	  bacterial	  fitness.	  	  Many	  of	  the	  cell	  wall	  associated	  proteins	  in	  the	  pneumococcus,	  including	  LytA,	  bind	  to	  the	  choline	  containing	  teichoic	  acids	  that	  form	  part	  of	  the	  lattice	  of	  the	  cell	  wall.	  These	  proteins	  are	  involved	  in	  many	  aspects	  of	  colonization	  and	  virulence	  of	  the	  pneumococcus	  (81).	  	  The	  phenotypic	  effects	  related	  to	  LytA	  could	  be	  due	  to	  a	  change	  in	  localization	  due	  to	  altered	  accessibility	  of	  the	  choline	  binding	  domains	  of	  these	  proteins	  to	  the	  teichoic	  acids	  in	  the	  cell	  wall.	  We	  attempted	  to	  test	  this	  hypothesis	  by	  washing	  Spn1+	  and	  Spn1-­‐	  strains	  with	  2%	  choline,	  which	  removes	  all	  choline	  binding	  proteins	  from	  the	  surface	  of	  the	  pneumococcus,	  and	  then	  performing	  a	  western	  blot	  for	  both	  LytA	  and	  the	  surface	  binding	  protein	  involved	  in	  adherence,	  PspA,	  which	  would	  indicate	  the	  quantity	  of	  choline	  binding	  proteins	  on	  the	  surface.	  	  We	  did	  not	  see	  a	  difference	  in	  the	  amount	  of	  LytA	  or	  PspA	  bound	  to	  the	  surface,	  however	  this	  assay	  would	  not	  indicate	  differences	  in	  localization	  of	  choline	  binding	  proteins	  on	  the	  cell	  wall.	  	  
Possible	  alternative	  structures	  of	  the	  cell	  wall	  
	  Though	  we	  have	  established	  several	  phenotypic	  differences	  associated	  with	  Spn1	  that	  are	  indicative	  of	  a	  change	  in	  the	  cell	  wall,	  we	  have	  not	  determined	  exactly	  what	  this	  change	  might	  be.	  There	  are	  many	  possible	  changes	  including	  thickening	  of	  the	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cell	  wall,	  increased	  crosslinking,	  changes	  in	  amount	  of	  teichoic	  acids	  and	  modifications	  to	  the	  glycan	  backbone.	  	  Thickening	  of	  the	  cell	  wall	  in	  response	  to	  environmental	  stress	  has	  been	  seen	  in	  the	  
S.	  aureus	  response	  to	  vancomycin	  (34).	  	  In	  this	  study,	  simple	  electron	  micrographs	  were	  sufficient	  to	  see	  the	  change	  in	  the	  thickness	  of	  the	  cell	  wall.	  	  In	  our	  study,	  no	  difference	  could	  be	  seen	  in	  micrographs	  comparing	  Spn1+	  and	  Spn1-­‐	  strains	  and	  measurements	  using	  ImageJ	  analysis	  showed	  no	  difference	  (Figure	  1A&B).	  	  It	  is	  possible	  that	  a	  smaller	  change,	  not	  visible	  by	  this	  technique	  is	  occurring.	  	  	  	  Penicillin	  and	  LytA	  both	  act	  (directly	  or	  indirectly)	  on	  the	  peptide	  crosslinks	  of	  the	  peptidoglycan.	  There	  is	  a	  large	  variation	  in	  pneumococcal	  muropeptides,	  the	  unit	  of	  the	  cell	  wall	  consisting	  of	  a	  peptide	  chain	  linked	  to	  a	  unit	  of	  the	  glycan	  backbone.	  	  Isolated	  muropeptides	  can	  vary	  in	  length	  of	  the	  peptide	  chain	  (three	  four	  or	  five	  peptides),	  the	  amount	  of	  crosslinks	  between	  peptide	  chains	  (monomeric,	  dimeric	  or	  trimeric)	  and	  branching	  (containing	  either	  a	  Ser-­‐Ala,	  Ala-­‐Ala	  branch	  or	  no	  branch	  at	  all)	  (29).	  	  The	  regulation	  responsible	  for	  these	  differences	  in	  the	  pneumococcus	  is	  unknown.	  Changes	  in	  the	  composition	  of	  peptide	  chains	  within	  the	  peptidoglycan	  could	  be	  conferring	  the	  resistance	  to	  LytA	  and	  penicillin	  mediated	  lysis	  phenotypes	  in	  the	  Spn1+	  strain.	  	  The	  phenotypes	  related	  to	  LytA	  and	  Mml	  are	  indicative	  of	  the	  change	  in	  the	  cell	  wall	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being	  related	  to	  maturation	  of	  the	  peptidoglycan.	  LytA	  mutants	  typically	  have	  the	  dual	  phenotype	  of	  lack	  of	  autolysis	  and	  long	  chain	  formation	  (130).	  	  In	  the	  Spn1+	  strain	  we	  see	  delayed	  autolysis,	  indicating	  resistance	  to	  LytA	  but	  shorter	  chain	  formation	  indicating	  an	  increase	  in	  sensitivity	  to	  LytA.	  At	  the	  septum,	  where	  LytA	  and	  LytB	  are	  involved	  in	  septation,	  there	  is	  either	  very	  little	  cross-­‐linking,	  or	  a	  specific	  type	  of	  cross-­‐linking	  making	  it	  easier	  for	  these	  enzymes	  to	  act	  at	  this	  site.	  	  As	  the	  peptidoglycan	  matures	  increased	  cross-­‐linking	  is	  observed	  (87).	  This	  may	  mean	  that	  increased	  crosslinking	  during	  peptidoglycan	  maturation	  leads	  to	  the	  seemingly	  contrary	  LytA	  phenotypes	  in	  autolysis	  and	  chain	  length.	  	  These	  two	  phenotypes	  could	  also	  indicate	  the	  localization	  of	  Mml.	  	  Since	  it	  is	  involved	  in	  chain	  formation,	  but	  not	  autolysis,	  Mml	  is	  likely	  localized	  to	  the	  septum.	  It	  is	  known	  that	  during	  exponential	  growth	  LytA	  is	  localized	  to	  the	  nascent	  peptidoglycan	  (104).	  	  Also,	  LytA	  and	  the	  phage	  lysin	  of	  phage	  SV-­‐1	  are	  likely	  co-­‐secreted	  in	  a	  choline	  dependent,	  holin	  independent	  manner	  (56).	  Both	  of	  these	  studies	  support	  the	  idea	  that	  Mml	  is	  localized	  at	  the	  septum.	  	  The	  pneumococcus	  modifies	  its	  cell	  wall	  in	  order	  to	  resist	  host	  defenses	  such	  as	  lysozyme.	  	  Specifically,	  the	  enzyme	  PgdA	  deacetylates	  the	  Gluc-­‐nac	  residue	  on	  the	  glycan	  backbone	  of	  the	  peptidoglycan	  to	  resist	  the	  muramidase	  activity	  of	  lysozyme	  (41).	  Comparison	  of	  Spn1+	  and	  Spn1-­‐	  strains	  showed	  no	  LytA	  independent	  difference	  in	  resistance	  to	  lysozyme	  (data	  not	  shown).	  	  It	  is	  unlikely	  that	  there	  is	  a	  change	  in	  the	  glycan	  backbone	  of	  the	  cell	  wall	  since	  the	  phenotypes	  observed	  of	  the	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Spn1+	  strain	  in	  autolysis	  and	  pencillin	  resistance	  are	  related	  to	  the	  peptide	  cross-­‐links.	  However,	  the	  importance	  of	  changes	  to	  the	  glycan	  backbone	  during	  colonization	  has	  laid	  the	  groundwork	  for	  the	  importance	  of	  the	  structural	  components	  of	  the	  cell	  wall	  as	  a	  target	  for	  host	  defenses	  in	  vivo.	  	  Lastly,	  the	  cell	  wall	  change	  associated	  with	  Spn1	  could	  be	  within	  the	  teichoic	  (WTA)	  and	  lipoteichoic	  (LTA)	  acids.	  WTA	  is	  made	  up	  of	  repeating	  units	  and	  can	  differ	  in	  length.	  Also	  the	  amount	  of	  phosphoryl	  choline	  bound	  to	  each	  of	  these	  units	  is	  variable.	  These	  two	  aspects	  of	  the	  WTA	  are	  thought	  to	  be	  the	  same	  in	  LTA	  (29).	  Length	  and	  amount	  of	  choline	  would	  likely	  alter	  accessibility	  of	  WTA	  and	  LTA	  to	  choline	  binding	  proteins,	  which,	  as	  I	  have	  already	  mentioned,	  are	  frequently	  important	  for	  pneumococcal	  virulence.	  Specifically,	  the	  availability	  of	  WTA	  and	  LTA	  to	  LytA	  for	  binding	  to	  the	  cell	  surface	  could	  affect	  the	  phenotypes	  of	  autolysis	  and	  chain	  length.	  	  
Mechanism	  of	  Spn1	  effect	  on	  cell	  wall	  
	  Though	  we	  can	  detect	  phenotypic	  differences	  associated	  with	  the	  presence	  of	  Spn1	  we	  have	  not	  determined	  a	  mechanism	  by	  which	  Spn1	  may	  be	  affecting	  these	  changes.	  It	  is	  possible	  that	  an	  unknown	  gene	  on	  Spn1	  is	  directly	  involved	  in	  altering	  the	  cell	  wall.	  However,	  it	  is	  also	  possible	  that	  expression	  of	  holins	  and	  lysins	  has	  led	  to	  a	  general	  stress	  response	  by	  the	  bacteria.	  	  Three	  stress	  response	  systems	  in	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Streptococcus	  pneumoniae,	  the	  Clpl	  heat	  shock	  protein	  and	  the	  CiaRH	  	  and	  WalRK	  two	  component	  systems,	  have	  been	  shown	  to	  lead	  to	  changes	  in	  bacterial	  physiology	  including	  the	  structure	  of	  the	  cell	  wall.	  	  	  The	  heat	  shock	  protein	  ClpL	  affects	  the	  pneumococcal	  cell	  wall	  and	  penicillin	  resistance	  (146).	  In	  response	  to	  heat	  shock,	  a	  commonly	  used	  stress	  inducer,	  ClpL	  upregulates	  transcription	  of	  the	  pbp2X	  gene	  and	  directly	  interacts	  with	  Pbp2X	  helping	  it	  translocate	  across	  the	  membrane.	  Penicillin	  binding	  proteins	  are	  largely	  responsible	  for	  crosslinking	  the	  peptide	  bridges	  of	  peptidoglycan.	  In	  this	  study	  they	  also	  saw	  a	  ClpL	  dependent	  thickening	  of	  the	  cell	  wall,	  which	  may	  indicate	  that	  it	  is	  not	  involved	  in	  the	  Spn1	  associated	  effects.	  	  The	  two	  component	  WalRK	  system,	  responds	  to	  stress	  and	  regulates	  several	  genes	  that	  modify	  the	  peptidoglycan	  in	  Streptococcus	  pneumoniae.	  The	  WalRK	  system	  has	  been	  shown	  to	  respond	  to	  oxidative	  stress	  and	  mutations	  in	  this	  pathway	  lead	  to	  resistance	  to	  vancomycin	  and	  daptomycin	  (51).	  The	  regulon	  of	  WalRK	  includes	  the	  essential	  PcsB	  protein,	  which	  works	  in	  conjunction	  with	  FtsXSpn	  a	  protein	  involved	  in	  cell	  division	  (134).	  WalRK	  also	  regulates	  several	  non-­‐essential	  peptidoglycan	  hydrolases	  and	  carboxy-­‐peptidases,	  including	  LytB,	  that	  can	  alter	  cell	  morphology	  (11).	  The	  role	  for	  WalR	  and	  WalK	  in	  vivo	  is	  strain	  dependent	  with	  some	  studies	  showing	  virulence	  defects	  in	  WalR	  or	  WalK	  mutants	  and	  others	  reporting	  no	  difference	  between	  WalR	  and	  WalK	  mutants	  and	  wild-­‐type	  strains	  (51).	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  There	  are	  several	  questions	  brought	  up	  in	  the	  previous	  discussion	  that	  merit	  further	  experimentation.	  	  I	  discussed	  the	  possibility	  that	  phage	  stability	  is	  indicative	  of	  a	  difference	  in	  the	  model	  host	  versus	  the	  natural	  host.	  	  To	  test	  this	  we	  could	  repeat	  the	  experimental	  human	  carriage	  studies	  to	  test	  competitive	  fitness	  of	  the	  Spn1+	  and	  Spn1-­‐	  strains.	  	  Furthermore,	  we	  could	  look	  at	  samples	  from	  epidemiology	  studies	  on	  co-­‐colonization	  to	  see	  if	  the	  presence	  of	  Spn1	  correlates	  with	  a	  lack	  of	  co-­‐colonizing	  strains.	  Lytic	  phage	  stocks	  of	  CP-­‐1	  and	  DP-­‐1	  are	  available	  commercially	  and	  could	  be	  used	  to	  check	  for	  phage	  resistance	  in	  the	  Spn1+	  strain.	  	  Though	  it	  is	  unlikely	  that	  Spn1	  confers	  a	  resistance	  to	  these	  phages	  because	  they	  are	  not	  of	  the	  same	  family,	  they	  are	  amongst	  the	  most	  common	  virulent	  phages	  found.	  	  Another	  future	  direction	  is	  to	  uncover	  the	  mechanism	  by	  which	  Spn1	  confers	  a	  change	  in	  the	  cell	  wall	  and	  therefore	  lead	  to	  a	  defect	  during	  colonization.	  One	  possible	  technique	  to	  pursue	  this	  question	  is	  using	  RNAseq	  to	  determine	  differences	  in	  bacterial	  gene	  transcription	  between	  Spn1+	  and	  Spn1-­‐	  strains.	  	  We	  could	  then	  look	  more	  specifically	  at	  the	  genes	  involved	  in	  the	  pneumococcal	  stress	  response,	  such	  as	  the	  genes	  regulated	  by	  the	  CiaRH	  system	  or	  WalRK	  system	  and	  clpL	  using	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qRT-­‐PCR.	  	  To	  further	  determine	  the	  regulation	  by	  these	  two	  compnent	  systems	  we	  could	  use	  western	  blots	  to	  determine	  the	  phosphorylation	  status	  of	  the	  signaling	  component	  of	  each	  of	  these	  two	  component	  systems.	  We	  could	  also	  look	  downstream	  of	  these	  regulatory	  genes	  at	  transcript	  levels	  of	  PBPs	  and	  see	  if	  changes	  in	  PBP	  transcription	  are	  dependent	  on	  the	  CiaR/H	  system,	  WalRK	  system	  or	  ClpL.	  	  	  To	  test	  the	  effects	  of	  metabolic	  burden	  we	  could	  remove	  large,	  non-­‐specific	  sections	  of	  phage	  genes.	  	  If	  fitness	  correlates	  roughly	  with	  numbers	  of	  genes	  removed,	  but	  not	  any	  one	  specific	  gene,	  it	  could	  be	  simply	  an	  effect	  of	  protein	  synthesis	  burden.	  	  This	  method	  could	  also	  potentially	  identify	  a	  specific	  phage	  gene	  involved	  in	  the	  fitness	  defect	  and/or	  the	  change	  in	  the	  cell	  wall.	  	  The	  best	  way	  to	  determine	  the	  exact	  change	  in	  the	  cell	  wall	  is	  by	  isolating	  the	  different	  components	  of	  the	  peptidoglycan	  and	  using	  biochemical	  analyses	  to	  determine	  variations	  in	  branching	  or	  crosslinking	  between	  the	  Spn1+	  and	  Spn1-­‐	  strain.	  	  After	  purification	  of	  the	  peptidolglycan,	  treatment	  with	  LytA	  will	  separate	  glycan	  strands	  from	  peptides.	  Treatment	  with	  cellosyl	  will	  cleave	  the	  peptidoglycan	  into	  muropeptides.	  Analysis	  of	  glycan	  strands	  by	  HPLC	  will	  indicate	  length	  of	  glycan	  strands,	  which	  is	  indicative	  of	  their	  acetylation.	  Analysis	  of	  muropeptides	  by	  HPLC	  and	  mass	  spectrometry	  will	  indicate	  glycan	  modifications,	  cross-­‐linking	  and	  length	  of	  peptide	  chain.	  WTA	  can	  be	  isolated	  from	  cell	  wall	  treated	  with	  both	  cellosyl	  and	  LytA	  by	  size	  exclusion	  chromatography.	  Mass	  spec	  analysis	  of	  the	  WTA	  will	  indicate	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number	  of	  repeats	  and	  amount	  of	  phosphocholine	  within	  a	  chain.	  Once	  the	  exact	  change	  in	  the	  cell	  wall	  is	  determined	  it	  may	  be	  easier	  to	  determine	  the	  mechanism	  by	  which	  Spn1	  confers	  this	  change.	  (29)	  	  Lastly,	  it	  would	  be	  interesting	  to	  determine	  if	  the	  relationship	  between	  Spn1	  and	  P1121	  is	  unique	  or	  if	  it	  is	  found	  in	  other	  pneumococcal	  strains.	  We	  could	  first	  look	  at	  similar	  phages	  such	  as	  phage	  040922	  and	  the	  bacterial	  isolate	  it	  was	  found	  in	  to	  see	  if	  phage	  gene	  expression	  is	  similar	  to	  what	  we	  see	  in	  Spn1.	  We	  could	  then	  follow	  up	  with	  assays	  to	  assess	  fitness	  and	  physiology	  in	  this	  pair.	  We	  could	  also	  design	  a	  PCR	  based	  prophage	  typing	  assay	  specific	  to	  Spn1-­‐like	  phages	  and	  use	  it	  to	  test	  large	  strain	  collections	  of	  the	  pneumococcus.
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Conclusions	  	  Although	  many	  phages	  confer	  a	  fitness	  advantage	  to	  their	  bacterial	  host	  during	  colonization	  and	  disease,	  the	  phage	  element	  Spn1	  does	  the	  opposite	  during	  colonization	  in	  a	  murine	  model.	  This	  phage	  element	  is	  novel	  and	  has	  a	  unique	  symbioses	  with	  its	  bacterial	  host,	  the	  pneumococcal	  strain	  P1121.	  	  Spn1	  expresses	  both	  lytic	  and	  lysogenic	  genes	  within	  a	  normal	  growing	  population.	  This	  is	  different	  from	  the	  carefully	  controlled	  gene	  expression	  seen	  in	  wild-­‐type	  lambda	  phages.	  For	  some	  unknown	  reason,	  the	  bacteria	  is	  tolerating	  the	  presence	  of	  Spn1	  rather	  than	  eliminating	  it.	  However,	  this	  tolerance	  has	  led	  to	  physiological	  changes	  in	  the	  bacterium	  that	  may	  result	  in	  decreased	  fitness	  in	  vivo.	  	  The	  Spn1+	  and	  Spn1-­‐	  strains	  both	  colonize	  the	  murine	  nasopharynx	  adequately.	  However,	  when	  assessed	  in	  a	  competitive	  assay,	  the	  Spn1-­‐	  strain	  outcompeted	  the	  Spn1+	  strain.	  This	  fitness	  advantage	  was	  dependent	  on	  phage	  gene	  expression.	  Other	  phenotypes	  associated	  with	  the	  presence	  of	  Spn1	  all	  indicate	  a	  change	  in	  the	  cell	  wall.	  Spn1	  confers	  a	  resistance	  to	  LytA	  mediated	  autolysis	  and	  to	  lysis	  by	  the	  action	  of	  penicillin.	  Both	  of	  these	  phenotypes	  reflect	  possible	  changes	  in	  the	  peptide	  crossbridges	  within	  peptidoglycan.	  Spn1	  also	  affects	  bacterial	  chain	  formation.	  The	  phenotypes	  of	  chain	  length	  and	  the	  protein	  LytA	  have	  both	  been	  found	  to	  be	  important	  during	  colonization.	  	  We	  separated	  those	  phenotypes	  from	  the	  genotypic	  presence	  of	  Spn1.	  Neither	  chain	  length	  nor	  LytA	  were	  important	  for	  the	  fitness	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Figure 2. Relative protein content associated with Spn1 A. Total content as determined 
by BCA assay normalized by OD after mild sonication to break up chains. Supernatant 
(S) and pellet (P) assayed after 1 hour of ultracentrifugation B. Total protein content 
assayed and normalized the same as in A with and without mitomycin C treatment. “ns” 


































Figure 3. The effect of holins on pneumococcal fitness A. Growth as determined by OD 
in Tryptic Soy broth with 10ng/ml of penicillin over 5 hours B. Competition between the 
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